In vitro expression, purification and biochemical characterization of KNL2 protein of Arabidopsis thaliana by Sandmann, Michael
Friedrich-Schiller-Universität Jena 
Biologisch-Pharmazeutische Fakultät 
Institut für Allgemeine Botanik and Pflanzenphysiologie 
Lehrstuhl für Pflanzenphysiologie 
 
Leipniz-Institut für Pflanzengenetik und Kulturpflanzenforschung 
Abteilung: Cytogenetik und Genomanalyse 
Arbeitgruppe: Karyotypenevolution 
 
 
 
 
In vitro expression, purification and biochemical characterization of 
KNL2 protein of Arabidopsis thaliana 
Diplomarbeit 
zur Erlangung des Grades eines 
Diplom-Biochemikers 
vorgelegt von 
Michael Sandmann 
aus Gera 
 
Jena, 28.06.2013 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gutachter: 
Dr. Inna Lermontova 
Prof. Dr. Ralf Oelmüller 
 Abstract 
 
Living cells are propagating by cell division. In eukaryotes, replicated chromosomes are 
separated by the microtubule apparatus, which attaches to the chromosomes via the 
kinetochore. The kinetochore is a large protein complex anchored at specific sites of the 
chromosomes: the centromeres. In many eukaryotes including human and Arabidopsis, the 
centromere is not exclusively determined by its sequence. Instead, the centromere-specific 
variant of histone H3 (CenH3) is regarded as the central molecule for centromere identity. 
CenH3 deposition is regulated by a variety of proteins. For instance, the human protein 
KNL2 is localized at centromeres shortly before CenH3 and mediates CenH3 loading by 
modulating the chromatin state of the centromeres and recruiting CenH3 loading factors.  
In this study the KNL2 homologue of Arabidopsis thaliana was characterized. 
Recombinant Arabidopsis full-length KNL2 protein and its N- and C-terminal parts were 
purified and used as substrates for a kinase assay, for a DNA binding assay and for the 
production of antibodies against the C-terminal part. The antibodies were used for 
immunostaining and Western blot experiments. The obtained data showed that Arabidopsis 
KNL2 localizes to the chromocenters during interphase, but not during mitosis. Similar 
localization was observed by Lermontova et al. (2013) using KNL2-EYFP fusion 
constructs stably transformed in Arabidopsis. KNL2 SALK mutants showed absence of 
KNL2 immunosignals at chromocenters and specific Western blot signals compared to 
wild type. Arabidopsis KNL2 is phosphorylated by Aurora kinase 3. This phosphorylation 
is possibly responsible for the absence of KNL2 at chromocenters during mitosis. 
Furthermore, a DNA binding capability of the C-terminal part is indicated. These 
observations match with current data in human KNL2 (Maddox, 2013).  
 Zusammenfassung 
 
Zellen vermehren sich durch Zellteilung. Replizierte Chromosomen werden in Eukaryoten 
durch eine koordinierte Bewegung von Mikrotubuli getrennt. Dabei sind die 
Chromosomen über den Kinetochorapparat mit den Mikrotubuli verbunden. Der 
Kinetochorapparat besteht aus einem Multi-Protein-Komplex, welcher auf bestimmten 
Chromosomenabschnitten, den Zentromeren, verankert ist. Die Identität der Zentromere 
wird in vielen Eukaryoten, unter anderen bei Menschen und Arabidopsis, nicht 
notwendigerweise durch eine bestimmte DNS-Sequenz determiniert. Stattdessen wird die 
zentromerische Variante von Histon H3 (CenH3) als zentrales Molekül angesehen, 
welches die Identität des Zentromers vermittelt. Die Beladung der Zentromere mit CenH3 
ist über eine Vielzahl von Proteinen geregelt. Eines dieser Proteine ist das bei Menschen 
identifizierte KNL2. Kurz vor der Beladung von CenH3 lokalisiert es am Zentromer, 
moduliert das zentromerische Chromatin und rekrutiert weitere CenH3 Beladungsfaktoren.  
Gegenstand dieser Arbeit ist die Charakterisierung eines homologen Proteins vom 
humanen KNL2 aus Arabidopsis thaliana. Rekombinantes KNL2 Gesamtprotein, sowie N- 
und C-terminale Fragmente, wurden aufgereinigt und anschließend als Substrate für 
Kinase-Tests, DNS-Bindingstests und für die Herstellung von Antikörper gegen den C-
terminalen Teil benutzt. Die Antikörper dienten zur Durchführung von Immunfärbung und 
Western Blot Experimenten. Die Ergebnisse dieser Experimente zeigten, dass KNL2 aus 
Arabidopsis thaliana sich in den Chromozentren der Kerne anreichert. Dies geschieht 
während der Interphase, jedoch nicht in der Mitose. Stabil transformierte KNL2-EYFP 
Konstrukte in Arabidopsis zeigten ähnliche Lokalisationen auf (Lermontova et al., 2013). 
Weder die chromozentrischen Signale noch KNL2-spezifische Western Blot Signale 
wurden in Proben von KNL2 SALK Mutanten gefunden. Ein Kinase-Test zeigte, dass 
Arabidopsis-KNL2 von Aurora Kinase 3 phosphoryliert wird. Diese Phosphorylierung 
könnte ein Grund für die Abwesenheit von KNL2 während der Mitose darstellen. Des 
Weiteren liefern die Ergebnisse dieser Arbeit Indizien für eine DNS-Bindefähigkeit im C-
terminalen Teil von KNL2. Letzteres findet sich auch im humanen KNL2 Protein 
(Maddox, 2013).  
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1 Introduction 
 
1.1 Cell cycle in eukaryotic organisms 
 
Living cells reproduce themselves to maintain their existence over million of generations. 
This could be done by an asexual or sexual process (Lodish et al., 2000).  
1.1.1 Asexual cell division 
A case of asexual reproduction: One eukaryotic ‘parent’ cell generates two daughter cells 
with the genome of the parent in a cell cycle. The cell cycle consists of 4 phases: the S 
phase, in which the DNA is replicated, the M phase, in which the two replicates – the sister 
chromatids – and the cytoplasm are separated, and two gap phases (G1 and G2), which 
connects M and S phase. G1, S and G2 together are also known as interphase (Cooper, 
2000).  
1.1.1.1 Interphase of the cell cycle 
G1 is the gap phase from M to S phase. S phase is a period of DNA replication. The 
replicated sister chromatids join together at their centromeres up to the beginning of the 
anaphase (Alberts et al., 2002). The centromeres are defined as the primary constriction of 
the chromosomes (see 1.2) (De Rop et al., 2012). In mammalians, the S phase occupies 
about the half of the cell cycle (Alberts et al., 2002). G2 is the connection between S to M 
phase. G1 and G2 phase are growth phases, in which the cell synthesize protein and 
increase the number of organelles to compensate cytoplasmic division and prepare for the 
replication and separation of the genome. Additionally cells monitor the environment 
during these phases. Especially unfavorable conditions during G1 lead the cell to enter the 
specialized resting phase G0, which can be switch back to G1 later under suitable 
conditions (Alberts et al., 2002).  
1.1.1.2 M phase of the cell cycle 
M phase is divided into sub-phases: mitosis or nuclear division, and cytokinesis or 
cytoplasmic division (Alberts et al., 2002).  
The mitosis can be subdivided in 5 stages: prophase, prometaphase, metaphase, anaphase 
and telophase. In prophase, the chromosomes begin to condense and the formation of the 
mitotic spindle apparatus with two poles starts. In the next stage, nuclear envelope breaks 
down, the attachment of the spindle apparatus to chromosomes via kinetochores begins and 
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the chromosome movement starts. The kinetochore is a molecular apparatus, which 
consists of DNA and proteins and maintains chromosome segregation (Karpen and 
Allshire, 1997; Sullivan et al., 2001). In metaphase, the kinetochore of each sister 
chromatid attach to spindle apparatus and the chromosomes are aligned between the 
spindle poles in an equatorial orientation. During anaphase spindle apparatus mediates 
segregation of sister chromatids. In the last stage, the chromatids arrive at the poles and 
decondense, two new nuclear envelopes form around the two separated sets of sister 
chromatids, as well as the contractile ring assembles, which herald the cytokinesis (Alberts 
et al., 2002). 
The contractile ring divides the cytoplasm during cytokinesis. This lead to the generation 
of two daughter cells and it completes the asexual cell division (Alberts et al., 2002). 
1.1.2 Sexual cell division 
The eukaryotic sexual reproduction cycle consists of the fusion of two haploid cells to a 
diploid one and the division of a diploid cell in two haploids by meiosis. Haploid cells 
require a reduced number of homologue chromosomes; otherwise, the chromosome 
number will multiple with every fusion. Meiosis achieves the haploid level of a replicated, 
diploid genome by a two step process: the division I of meiosis, which is a separation of 
the homologue chromosomes; and the division II of meiosis, which resembles mitosis. 
Therefore, the separation of the sister chromatids occurs in division II (Lodish et al., 2000; 
Alberts et al., 2002). Haploid or diploid cells can undergo mitosis and maintain the 
proliferation depending on the species. In animals, the diploid state is the preferred state 
for proliferation, in fission yeast it is the haploid state and plants show either one of both 
states (Alberts et al., 2002). 
 
1.2 Centromeres and centromere identity 
 
A coordinated separation of chromosomes is crucial in mitosis and meiosis. The 
centromeres play an important role in this process. Centromeres are the primary 
constriction of metaphase chromosomes and consist of DNA and protein parts (van der 
Ploeg et al., 1974; Sullivan et al., 1996; Fang and Spector, 2005). The centromeres of 
plants and animals contain regions of highly repetitive satellite DNA (Henikoff et al., 
2001). Typical centromeric repeats of Arabidopsis thaliana are 500-1000 kb regions with a 
characteristic length of 180 bp (referred as cen180). Moreover, transcribed regions like 5s 
rDNA or genes like the phosphoenolpyruvate phosphate translocator are found in 
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Arabidopsis centromeres. The centromeric sequences have a decreased level of 
recombination in Arabidopsis (Copenhaver et al., 1999). 
The centromeres are the chromosomal positions, where the kinetochore assembles 
(Lermontova and Schubert, 2013). The kinetochore consists of the inner kinetochore, a 
protein network attached to DNA, which are necessary for kinotochore assembly; and the 
outer kinetochore, which maintains microtubule binding (Pluta et al., 1995). The question 
arise how the centromere is recognized by the kinetochore and how the centromere is 
identified?  
The sequence of centromeres is not regarded to maintain solely centromere function or 
identity in higher eukaryotic organism (Warburton et al., 1997; Henikoff et al., 2001; 
Nasuda et al., 2005). In contrast, the ‘point centromere’ and its sequence of Saccharomyces 
cerevisiae is known to be necessary for proper mitosis (Pluta et al., 1995; Sullivan et al., 
2001). “The primary sequence of centromeric DNA is not conserved among species, or 
even among different chromosomes of individual organism.”(Karpen and Allshire, 1997) 
The appearance of higher ratios of adenine/thymine pairs and the embedding in 
heterochromatic, pericentromeric regions are the known similarities of eukaryotic 
centromeres (Karpen and Allshire, 1997; Sullivan et al., 2001; Fang and Spector, 2005). 
The lack of a common, high conserved DNA element in centromeres indicates the 
existence of other mechanisms mediating kinetochore assembly. The phenomenon of 
‘neocentromeres’ formation, which do not require typical centromeric sequences, supports 
this indication (Peacock et al., 1981; Brown and Tyler-Smith, 1995; Depinet et al., 1997; 
Karpen and Allshire, 1997; Warburton et al., 1997). Neocentromeres can carry out normal 
centromere function and are established on the basis of epigenetic mechanism (Maggert 
and Karpen, 2000). In vivo studies shows that epigenetic changes can activate 
nonfunctional eukaryotic centromeres (Steiner and Clarke, 1994). Some examples for 
epigenetic, centromere-characteristic changes, which appear also in Arabidopsis, are 
described below.  
1) Centromeres and neocentromeres are hypermethylated at cytosines of CpG 
dinucleotides. However, some pockets of centromeric sequences are in non-methylated 
state and show transcriptional activity (Wong et al., 2006). 2) The di- or trimethylation on 
lysine 9 of histone H3 (H3K9me3/H3K9me2) are the major histone modifications at 
centromeric sites in maize and Arabidopsis (Shi and Dawe, 2006; Kim et al., 2012). 3) 
Some centromeric transposons and related tandem repeats were transcribed into dsRNA, 
which were subsequently configured into RNAi molecules by the RNAi machinery. These 
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RNAi molecules may affect histone 3 lysine 9 methylation, DNA methylation and they are 
involved in establishment and maintenance of (pericentromeric) heterochromatin (Volpe et 
al., 2002; Lippman et al., 2004). 4) Some studies refer to a ‘higher order structure’ of 
centromeric DNA sequences, which is specifically folded and can attract the kinetochore 
(Karpen and Allshire, 1997; Sullivan et al., 2001). 5) CenH3, which is a centromeric 
variant of histone H3, is regarded as central epigenetic mark for centromere identity 
(Sullivan et al., 2001; Panchenko et al., 2011) (see 0).  
In general epigenetic marks can be quite species specific (Shi and Dawe, 2006; Roudier et 
al., 2011) and although histone modifications are highly conserved, they should not be 
generalized among species (Fuchs et al., 2006).  
 
1.3 Epigenetic regulation at centromeric and pericentromeric sites in 
Arabidopsis 
 
CenH3 associated core centromeric satellite DNA of Arabidopsis thaliana and Zea mays 
are hypomethylated in comparison to their related pericentromic, heterochromatin-enriched 
regions. The centromeric hypomethylation is correlated with a significant reduced level of 
H3K9me2 on sequences with a distinct distribution of CG and CNG sites (Zhang et al., 
2008). Another study confirms the increased level of H3K9me2 methylation in 
Arabidopsis pericentromeric regions, where the dimethylation forms patterns of long and 
rarely interrupted blocks (Bernatavichute et al., 2008).  
In Arabidopsis H3K9me2 typically marks heterochromatin and regions of silenced 
transposons, whereas the H3K9me3 modification is in general associated with euchromatic 
sequences (Roudier et al., 2011; Veiseth et al., 2011). However, a locus-specific repression 
of transposons via an H3K9me3 signal is possible, too (Veiseth et al., 2011). DNA 
methylation and methylation of H3K9 position is performed by siRNA guided DDM1 
(Lippman et al., 2004). Additionally less H3K9me2 modification occurs in maize 
pericentromeric areas, however, H3K9me1 is enriched (Shi and Dawe, 2006). There are 
other important sites for epigenetic modifications like H3K4 (Roudier et al., 2011). 
Nevertheless, the H3K9 position emphasizes the diverse role of epigenetic modifications 
for centromere identity as one possible example.  
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CenH3 and its role in eukaryotic organisms 
 
CenH3 (alternative name: Htr12) in Arabidopsis, his mammalian equivalent CENPA, CID 
in fly or Cse4 in yeast replaces histone H3 in centromeric nucleosomes (Shelby et al., 
1997; Meluh et al., 1998; Sullivan et al., 2001). Classical octameric nucleosomes consist of 
dimers of histone H2A, histone H2B, histone H3 and histone H4 (Nechemia-Arbely et al., 
2012). Centromeric histone variant CenH3 could be seen as “evolutionary link between the 
seemingly divergent centromeres” (Sullivan et al., 2001) in eukaryotic organism. CenH3 
can carry out the transformation of non-centromeric regions to functional neocentromeres 
(Lo et al., 2001). In artificial LacI-LacO experiments, CenH3 is able to establish functional 
centromeres at predefined, stably integrated sites inside the Drosophila and Arabidopsis 
genome (Mendiburo et al., 2011; Teo et al., 2013). These findings show a self-propagating 
and heritable character of CenH3 as epigenetic mark, too. Furthermore, CenH3 can 
mediate higher-order chromatin structure, “modifies the entry/exit of the DNA from the 
nucleosome” (Nechemia-Arbely et al., 2012) and possibly change the packaging of 
nucleosome bound DNA (Tachiwana et al., 2011).  
The incorporation of CenH3 can be regarded as hallmark for centromere identity. Blocks 
of CenH3 together with blocks of histone H3 form the centromeric chromatin (Zhang et al., 
2008).  
Inactivation of CID leads to disrupted mitosis and cell-cycle progression in fly (Blower 
and Karpen, 2001) and Arabidopsis CenH3 knock-down causes dwarfism connected to a 
reduced number of mitosis as well as a reduced fertility due to disordered meiosis 
(Lermontova et al., 2011). Similar results can be found in other species (i.e.: mice 
(Howman et al., 2000), yeast (Meluh et al., 1998) or nematode (Oegema et al., 2001)). 
Moreover, these studies can also show that the proper localization of other kinetochore 
proteins depends on CenH3.  
1.3.1 Function of the N- and C-terminus of CenH3 
CenH3 homologues are less conserved among species than histone H3 despite of 
conserved function. This is especially true for the N-terminal tail and loop 1 of the C-
terminal region, which is not conserved (Henikoff et al., 2001; Cooper and Henikoff, 
2004). The C-terminal region of CenH3 contains the HFD domain, which is responsible for 
centromere specific DNA binding in eukaryotic organisms. The non-conserved loop 1 
region and the adjacent α2-helix of the HFD forms the CATD domain (Shelby et al., 1997; 
Lermontova et al., 2006; Perpelescu and Fukagawa, 2011; Nechemia-Arbely et al., 2012). 
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The “loop 1 in the CATD protrudes from the CENP-A nucleosome” (Nechemia-Arbely et 
al., 2012) and may attract some trans-acting centromeric compounds (Tachiwana et al., 
2011). The substitution of three certain, among plants conserved amino acids of the loop 1 
domain leads to abolished centromere targeting (Moraes et al., 2011). Therefore, these 
amino acids are necessary for centromere recognition and the loop 1 domain contains 
certain conserved and functional spots or maybe an adaptive evolution process occurs 
between centromeres and CenH3 is the basis on variable N-terminus or loop 1 of the 
CATD (Cooper and Henikoff, 2004). 
The role of the N-terminus seems to be divergent among species. In Saccharomyces 
cerevisiae, the N-terminus is involved in protein-protein interaction at the kinetochore 
(Chen et al., 2000). However, histone H3 containing CATD chimers can localize at 
centromeres and rescue growth of CENPA deficient human HeLa cells. Thus, the N-
terminus seems not to be necessary for kinetochore assembly in human (Black et al., 
2007). In Arabidopsis, the role of N-terminus of CenH3 differs between mitosis and 
meiosis. In mitosis, the C-terminal part is sufficient, however, for proper meiosis the N-
terminal part of CenH3 is also required (Lermontova et al., 2011; Ravi et al., 2011; 
Lermontova and Schubert, 2013). 
 
1.4 CenH3 assembly in Arabidopsis 
 
CenH3 localizes at cen180 positions of centromeres, but not at elements like Athila 
retrotransposons, which are especially enriched in pericentromeric regions (Nagaki et al., 
2003; Fang and Spector, 2005; Lermontova and Schubert, 2013). However, CenH3 
proteins are not loaded on the entire cen180 repeats. Chromatin fiber immunolabeling 
showed a loading of 12%-15% of cen180 repeats by CenH3 at the knobs on the extended 
chromatin fibers (Shibata and Murata, 2004; Lermontova and Schubert, 2013). The loading 
of CenH3 in Arabidopsis centromeres is happening mainly during G2 phase (Lermontova 
et al., 2006). In other phylogenetic groups, the loading of centromeric histones occur in 
different cell cycle phases (Lermontova et al., 2006; Nechemia-Arbely et al., 2012; 
Lermontova and Schubert, 2013). The reason behind this difference is unclear so far, 
maybe the non-conserved parts of CenH3 play a role.  
The incorporation of CenH3 at centromere is shown as essential for centromere identity 
and function. Therefore, the questions arise how CenH3 is loaded and which components 
are involved in loading mechanism? 
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1.4.1 Models of CenH3 loading 
There are different models of CenH3 loading/propagation: last to replicate model, or in 
contrast, the early to replicate model, nuclear organization model and cyclical chromatin 
model (Sullivan et al., 2001).  
The last/early replicate model can not be applied, because CenH3 assembly has to happen 
in S phase according to this model. The nuclear organization model requires distinct 
centromeric domains, where CenH3 assembly occurs at clustered centromeres. The 
Arabidopsis centromeres are usually distributed at the nuclear membrane, but do not 
cluster together (Lermontova et al., 2006). The cyclical chromatin assembly model relies 
on CAFs. This model might explain the assembly of new CenH3 histones in Arabidopsis. 
CenH3 and H3 nucleosomes are dispersively segregated on daughter strands during 
replication (Annunziato, 2005). CAFs replenish the free nucleosome sites according to 
remaining neighbor-nucleosomes. The assembly of histone H3 is dependant on S phase, 
whereas CenH3 not (Shelby et al., 2000; Sullivan et al., 2001). In human, HJURP is such a 
CAF, a histone chaperone, which can induce the formation of neocentromeres (see 1.2) 
(Barnhart et al., 2011). 
There are some models, which explain how the different loading of histone H3 and CenH3 
is organized. CAFs can possibly exchange CenH3 against ‘placeholder histones’ after 
histone H3 loading (Sullivan, 2001; Dunleavy et al., 2011). Also, the pericentromeric 
heterochromatin may block conventional nucleosome assembly. Therefore, later CenH3 
assembly is possible (Ahmad and Henikoff, 2001). Other findings in fly, human and yeast 
show that CenH3 can be present in tetrameric instead of classical octameric nucleosomes 
(Dalal et al., 2007; Bui et al., 2012; De Rop et al., 2012). During replication the octameric 
CenH3 nucleosomes might be split in two and divided on the daughter strands. This arises 
as a possible mechanism for an epigenetic inheritance throughout the whole cell cycle 
(Dalal et al., 2007; Bui et al., 2012). CAFs could hypothetically replenish octameric 
CenH3 nucleosomes in G2 phase (Lermontova et al., 2011). 
1.4.2 CenH3 licensing and maintenance 
The process of CenH3 loading can be subdivided into three parts: licensing, loading or 
deposition and maintenance (Lermontova et al., 2013). 1) In human and nematodes the 
Mis18 complex with its component KNL2 is annotated for the function of licensing and 
recognition (Fujita et al., 2007; Maddox et al., 2007; De Rop et al., 2012). This protein and 
its function are discussed in the next chapter. 2) The loading of CenH3 is shown in the 
previous chapter. 3) The maintenance of the newly incorporated CenH3 histones can be 
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carried by the GTPase activating human protein MgcRacGAP (Lagana et al., 2010; De 
Rop et al., 2012; Nechemia-Arbely et al., 2012). This protein can bind hsKNL2 and might 
activate other proteins, which are necessary for CenH3 maintenance and are recruited by 
hsKNL2 (Lagana et al., 2010).  
 
1.5 KNL2 homologues in other organisms 
 
C. elegans or human KNL2 have a C-terminal Myb/SANT domain (Maddox et al., 2007). 
The Myb domain is annotated with DNA binding (Lipsick, 1996) and the SANT domain 
binds modified histone tails or other modulating proteins and plays often a general role in 
chromatin dynamics and remodeling (Boyer et al., 2004). Myb and SANT domain shares 
high similarity on primary sequence of the DBD and secondary structure. However, SANT 
domain do not contain several conserved DNA-binding specific key residues of Myb DBD 
and is functional divergent to this similar domain (Boyer et al., 2004). Recent studies show 
a motif-independent DNA binding capability of nematode/human KNL2 (Maddox, 2013). 
Therefore, these homologues are annotated by a C-terminal Myb domain. 
In silico analysis can identify a SANTA domain in the N-terminal part of Arabidopsis 
KNL2 (Lermontova et al., 2013). SANTA domain could carry out protein-protein 
interaction, is associated with SANT domains and possibly regulates chromatin remodeling 
as well. Although SANTA and SANT are separate domains, there are functionally related 
and evolutionary linked (Zhang et al., 2006). Moreover, to the similarity of Myb and 
SANT domain, hints are gives, that our candidate and human or nematode KNL2 are 
related homologues. However, question about the functional background are still open. 
Homologues of KNL2 show an important role in CenH3 loading. “[C]entromeric 
localization [of mice KNL2] is essential for the subsequent recruitment of de-novo 
synthesized CENPA.” (Fujita et al., 2007) RNAi knock down of mice KNL2 shows 
abortion of CENPA loading and a disturbed mitosis (Fujita et al., 2007). Homologues of 
holocentric C. elegans or monocentric human show similar function and similar results for 
RNAi knock-down (Maddox et al., 2007). KNL2 depletion mimics CenH3 depletion. The 
loading of HsKNL2 happens during anaphase/mitotic exit to early G1 and CENPA loading 
occurs in late telophase/G1 phase in human HeLa cells (Maddox et al., 2007; Nechemia-
Arbely et al., 2012). So KNL2 seem to preludes CenH3. 
The HsKNL2 complex (Mis18) possibly plays a role in histone 4 acetylation, recruiting of 
DNA methyltransferases, H3K9me3/H3K9me2 or H3K4me2 modification, and it is 
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required for the recruitment of HJURP to endogenous centromeres (see 1.4.1). Therefore, 
HsKNL2 change the epigenetic mark of centromeres and ‘priming’ CenH3 loading 
(Barnhart et al., 2011; Perpelescu and Fukagawa, 2011).  
Additionally the primary sequence of KNL2 homologues contains certain conserved 
motifs, however, they differ in primary sequence (Maddox et al., 2007; Lermontova and 
Schubert, 2013). 
 
1.6 The regulation of KNL2 function 
 
1.6.1 Interaction between CenH3 and KNL2 
A direct interaction between CenH3 and HsKNL2 complex could not be found (Fujita et 
al., 2007; De Rop et al., 2012). However, a recent study shows that CENPC binds directly 
HsKNL2 and it is involved in HsKNL2 recruiting at centromeres (Moree et al., 2011). 
CENPC is part of the inner kinetochore (see 1.2) and binds CENPA. Therefore, CENPC 
provides a foundation for a CENPA-HsKNL2 network (Carroll et al., 2010). The function 
of KNL2 might not be relying on a close interaction between CenH3 and KNL2. 
 
1.6.2 Regulation of KNL2 by phosphorylation 
Additionally function of HsKNL2 depends on phosphorylation. HsKNL2 targets 
centromeres only in unphosphorylated state, furthermore, de-phosphorylation and 
deactivation of the related kinase happens at the loading time of HsKNL2 (Nechemia-
Arbely et al., 2012).  
 
1.7 Aim of the study 
 
In this study we want to produce recombinant Arabidopsis KNL2 in full length and as well 
as N- and C-terminal parts of it. The recombinant proteins are used for three purposes. 
Recombinant KNL2 shall be used as substrate in a kinase assay with Aurora kinases and as 
antigen for antibody production in rabbit. The antibodies should be used in 
immunostaining assays and CenH3-KNL2 co-localization experiments. Additionally we 
performed EMSA to look for a DNA binding capability like HsKNL2 (see 1.5). These 
preliminary experiments should give some insights for an uncharacterized Arabidopsis 
protein. 
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2 Methods 
 
2.1 Gateway based gene cloning 
 
For the expression of KNL2 protein and its N- and C-terminal parts (=KNL2 variants) in 
E. coli entry vectors were generated using the Gateway cloning technology (Life 
technologies®). cDNAs of KNL2 variants were amplified by PCR and cloned into the 
pDONR221 vector using BP clonase reaction (see 2.5, Supplemental Figure 1 & 
Lermontova et al. (2013)). The purification of attB – PCR products and the BP reaction 
were done according to Life technologies®’s manual. The BP reaction was set up 
according to the following scheme: 1-2 μl purified PCR product (20-50 fmol), 1 μl 
pDONR™221 (150 ng/μl, Life technologies®, 12536-017) and 2 μl BP clonase (Life 
technologies®); the total volume of the reaction was adjusted to 8 μl by TE buffer. After 
1h of incubation at room temperature the reaction was terminated by addition of 1 μl of 
proteinase K. To desalt samples and prepare them for transformation of E. coli by 
electroporation (see 2.2) a dialysis step was performed for 30 min on a filter membrane 
(Millipore, nitrocellulose filter 0.025 μm, #VSWP02500) against distilled water. 
pDONR221 vectors carrying the KNL2 variants were checked by PCR and sequencing 
(data not shown subsequently). Generated entry vectors were used for the recombination 
into the expression vector pDEST17 using the LR clonase reaction (Life technologies®) 
according to manufactures instructions with slight modifications. The incubation of the LR 
clonase reaction was reduced to 22°C. A nitrocellulose filter dialysis step was also carried 
out. The DNA concentration of the dialyzed LR clonase reaction was measured by 
nanodrop (see 2.7). The pDEST17, which contained the sequence of KNL2 variants, were 
checked by sequencing (see 2.9) and subsequently transformed into E. coli BL21 strain by 
electroporation to express recombinant KNL2 variants (see 2.2 & 2.11).  
 
2.2 Transformation of Escherichia coli by electroporation 
 
Dialyzed BP and LR clonase reactions were used for the transformation of E. coli strain 
DH5α to select positive clones. Cloned vectors were isolated from the positive selected 
cells (see 2.3) to obtain material for subsequent applications (see 2.1).  
Deep-frozen electroporation-competent E. coli cells (DH5α or BL21) were thawed on ice 
for 5-10 min with gentle mixing in between. 1-50 ng of dialyzed BP or LR clonase reaction 
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were added to 50 μl competent cells followed by gentle mixing. Electroporation was done 
at 2500 V with Easy Jet prima (Equi Bio®). Afterwards 500 μl of SOC medium was 
added, samples were incubated at 37°C for 1 h. 100 μl-250 μl culture was distributed onto 
sterile, pre-warmed selective LB-agar plates, which were subsequently incubated for 12 to 
16 h at 37°C. Only transformed, positive cells should grow on the selective, antibiotic 
containing medium.  
 
2.3 Plasmid isolation 
 
Liquid cultures were prepared with bacterial glycerol stocks (see 0), which were diluted 
1:100 in 3 to 5 ml sterile LB medium and incubated overnight at 37°C with shaking. 
QIAGEN®´s QIAprep™ spin Miniprep kit (#27106) was used for the plasmid isolation of 
liquid cultures according to manufacture’s manual. 
 
2.4 Polymerase chain reaction (PCR) for amplification of distinct DNA 
fragments 
 
PCR mastermix (see 3.1) was prepared. Template DNA was added 1:25 to the mastermix. 
The isolated (see 2.3) expression vector pDEST17 with KNL2 variant cDNA inserts was 
used as template in the experiment of chapter 4.1.1 and diluted (1:10000), isolated 
Arabidopsis genomic DNA (see 2.8) served as template for the generation of cen180 
fragments (see 4.2.1). Experiment dependent PCR programs were executed with the PCR 
machine of BioRad® (iCycler Thermo Cycler). The sequences of the forward and reverse 
primers and the PCR program are shown in the chapter 3.2.  
 
2.5 PCR sample purification 
 
QIAGEN®´s QIAquick® PCR purification kit protocol was used. Distilled water or 
10 mM tris HCl pH 7.5-8.5 served as eluent. 
 
2.6 Agarose gel electrophoresis for DNA analysis 
 
DNA gels were prepared according to Green and Sambrook (2012). In general, 1% agarose 
were used. Ultrapure agarose (Life technologies, #15510-027) was resuspended in 1x TBE 
buffer and boiled in microwave. DNA staining substance SYBR® safe (life technologies®, 
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S33102) was added after the liquid gel cooled down to approximately 60°C. For the 
loading, of DNA samples 4 volumes were mixed with 1 volume of 5x DNA loading buffer 
loaded into the polymerized gel. DNA markers (from Thermo Fisher Scientific®: SM0331 
and SM0613) were used for the estimation of DNA size of separated fragments. The 
stained DNA was visualized under a trans-illuminator (Syngene, Gene flash).  
 
2.7 Estimation of DNA concentration 
 
DNA concentration was estimated by measurement of DNA absorption at OD260 on 
nanodrop machine (prqlab® Biotechnologie´s ND-1000) according to producer’s manual. 
 
2.8 Extraction of genomic DNA from plant material 
 
Genomic DNA was isolated from ≤100 mg of leaf material of Arabidopsis according to the 
manufacturer’s manual of the plant DNA extraction kit (DNeasy® plant mini kit by 
QIAGEN®). Plant tissues were disrupted using Retsch®´s MM301 machine. Distilled 
water was used for the elution of the genomic DNA. The obtained gDNA served as 
template for the cen180 PCR (see 2.4).  
 
2.9 DNA Sequencing 
 
About 200 ng of isolated plasmid DNA (see 2.3 & 2.7) were used for sequencing by 
service team of Dr. Patrick Schweizer (IPK, Gatersleben). T7 promoter and T7 terminator 
primers were used (see 3.2). 
 
2.10 Sequence alignment 
 
DNA sequences were analyzed by a multiple sequence alignment tool (EMBL-EBI, Clustal 
Omega) to compare sequencing data (see 2.9) with annotated cDNA sequences or to 
compare different database identifiers (Supplemental Figure 8).  
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Generation of bacterial glycerol stocks 
 
Glycerol stocks were prepared with 3 volumes of liquid bacterial overnight culture (see 
2.11) and one volume of glycerol (100%) to store these bacterial cultures over long time. 
Alternatively the protocol of Green and Sambrook (2012) was used instead.  
 
2.11 Protein expression 
 
E. coli overnight cultures were grown in 1-10 ml of LB medium with addition of ampicillin 
(final concentration 200 μg/ml), which were inoculated by glycerol stocks (see 2.3 & 0) or 
single colonies grown on petri dishes with agar LB medium were picked. Liquid cultures 
were incubated overnight at 37°C with shaking at 180 rpm. 12-16 h old overnight cultures 
were inoculated in ampicillin containing (200 μg/ml), pre-warmed (37°C) LB medium 
with a minimum 1:100 dilution. Optionally, the overnight culture could be centrifuged 
(5000 g, 10 min, 4°C) and resuspended in ampicillin containing LB medium before 
inoculation. Then, the culture was growing at 37°C with shaking 180 rpm until bacterial 
culture reached OD600 values between 0.5-1.0 (Eppendorf, BioPhotometer, #6131). 
Usually OD 0.8 was targeted. Protein expression was induced by IPTG (final 
concentration) of 1 mM and new ampicillin was added. Samples were taken 3 h after 
induction and were subsequently centrifuged (5000 rpm, 15 min, 4°C). Supernatants were 
removed and samples were stored at -80°C until they were analysed by SDS-PAGE (see 
2.17) or solubility test (see 2.13), alternatively they were used for protein purification (see 
2.16.2). 
 
2.12 Total protein extraction from E. coli cells 
 
SDS gel-loading buffer was added to the pellet of induced bacterial culture (see 2.11). The 
volume of the buffer was 1/25 of the volume of bacterial culture before centrifugation. The 
resuspended pellet was warmed at 65°C for 15 min. A sonication step (compare 2.13.1) for 
1 min was performed to break the cells followed by a centrifugation (13000 rpm, 10 min, 
RT). The supernatant was heated at 95°C for 5 min. The samples were cooled down and 
were centrifuged (13000 rpm, 1 min, RT). The validation of the samples was performed by 
SDS-PAGE (see 2.17).  
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2.13 Solubility test  
2.13.1 Protein solubility analysis  
 
1 ml of bacterial culture (see 2.11) was taken 3h after IPTG induction and centrifuged at 
5000 rpm for 15 min. The pellet was dissolved in 100 μl of TE buffer. A suspension was 
sonicated (Sonics & Materials®, Vibra Cell; 60% power) for 90 s with a schedule of 5 s 
pulse time and 5 s interruption to destroy the cell wall. The sonicated sample was 
centrifuged at 13,000 rpm for 15 min. Then, 2 volumes of SDS gel-loading buffer was 
added to supernatant (soluble fraction) and 100μl of SDS gel-loading buffer dissolved the 
pellet (insoluble fraction). Subsequently the samples were analyzed by SDS-PAGE (see 
2.17).  
 
2.13.2 Solubility test according to Green and Sambrook (2012) 
 
The procedure was performed according to the named source with slight modifications. 
Benzonase (Benzonase® Nuclease #70746-4 by Novagen®/EMD Millipore) was used 
instead of DNase I (Thermo Fisher Scientific® #EN0521). The E. coli cells were disrupted 
by sonication in bacterial lysis buffer (compare 2.13.1). 
 
2.14 Protein extraction from Arabidopsis thaliana material 
 
100 mg of plant material (young seedlings) was frozen in liquid nitrogen and stored at 
-80°C or directly homogenized by mechanical disruption (Retsch MM301) for 30s at 30 
Hz. The homogenate was resuspended in 200 μl-1 ml of SDS gel-loading buffer. The 
samples were incubated for 10 min at 70°C with shaking at 800 rpm. A centrifugation step 
(13000 rpm, 5 min, RT) was carried out and supernatants (protein extracts) were 
transferred into new micro-reaction tubes. 
 
2.15 Determination of protein concentration by Bradford assay 
 
Proteins were first precipitated by 10% TCA to get rid of SDS and DTT, which are not 
compatible with Bradford solution, to determine protein concentration in protein extracts 
from Arabidopsis thaliana material (see 2.14) in gel-loading buffer.  
1 volume of Arabidopsis protein extract and 5 volumes of 10% TCA were mixed. Samples 
were incubated for 30 min on ice. A centrifugation (13000 rpm, 10 min, and 4°C) was 
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performed. Pellets were resuspended in 100 μl of 0.1 N NaOH. Bradford assay was done 
according to BioRad®´s Quick Start™ Bradford Protein Assay instruction. 10 or 20 μl of 
each protein samples dissolved in 0.1 N NaOH were transferred into new micro-reaction 
tubes. Then, 1 ml of protein staining dye 1x (BioRad® #500-0205) was added. After 5 min 
incubation at room temperature samples were measured at OD595 by the spectro-meter 
BioRad® SmartSpec Plus. BSA was used for calibration curve.  
Samples gained from protein purification (see 2.16.2) were dialyzed (compare 2.22 or 
2.28). The protein samples were compatible to Bradford assay after dialysis. The protein 
concentrations were used for the calculations of protein-DNA ratios in the EMSA assay 
(see 2.22).  
 
2.16 Protein purification after protein expression 
 
The recombinant KNL2 proteins, their transcription were induced by IPTG (see 2.11), 
have to be purified to omit bacterial protein and gain pure recombinant protein for other 
application like kinase assay, antibody production or EMSA (see 1.7, 2.22, 2.25 & 2.27). 
The His tag of the recombinant protein, which is encoded on the pDEST17 vector (see 
2.1), was used for a specific His tag purification. Two different approaches were applied. 
2.16.1 Protein purification with QuickPick™ IMAC PLUS 
The manual of the manufacturer ‘Bio-Nobile Oy’ were used for protein purification under 
denaturing conditions with one modification. The incubation time of the recombinant 
proteins in elution buffer was increased to 90 min to increase the yield of eluted, purified 
protein.  
 
2.16.2 Protein purification with Ni2+-NTA beads under denaturating conditions 
(batch method) 
Agarose beads slurry (Macherey-Nagel®, 745400.25 or QIAGEN®, 1000632) were equi-
librated two times in 1x PBS followed by two times equilibration in GuHCl pH 8 buffer. 
The frozen cell pellets of IPTG induced cultures (see 2.11) were resuspended in GuHCl 
pH 8 buffer with 1 mM PMSF and sonicated (Sonics & Materials®, Vibra Cell; 60% 
power) for 1-5 min until the solution get clear. PMSF is a serine proteinase inhibitor, 
which shall omit protein degradation. The sonicated cell suspensions were incubated for 1 
h with shaking. The pH of the suspensions were adjusted to pH 8 followed by a 
centrifugation (8000 g, 10 min, RT). Supernatants were combined with equilibrated beads. 
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The mixtures were incubated for 1 h with shaking to let the recombinant His tagged protein 
bind to the beads. Then, the samples were centrifuged (1000 g, 2 min, RT). Washing steps 
were performed by using urea containing buffers with pH 8 and pH 6 or optional with pH 
5.3 (see 3.1). The protein was eluted by urea containing buffers with pH 4 and pH 2.8. The 
volume of the elution buffer was equal to the volume of beads slurry. In the case the 
samples were eluted with buffers containing 0.01% Triton X-100, two washing steps with 
urea containing buffer with pH 6 (0.01% Triton X-100) were done after washing with urea 
pH 6 buffer containing 0.5% Triton X-100. 
 
2.17 Protein analysis with a Sodium dodecyl sulfate - polyacrylamide gel 
electrophoresis (SDS-PAGE) 
 
2.17.1 Tris-glycine based SDS-PAGE 
The gel preparation, sample preparation and gel electrophoresis was prepared according to 
Green and Sambrook (2012) with slight modifications. Modified buffers of SDS gel-
loading buffer and tris-glycine electrophoresis buffer were used. The percentage of 
acrylamide in the gel depended on every experiment. A correct chosen percentage can lead 
to a better separation of the protein of interest in the gel. The gels were run with 160 V in 
the electrophoresis apparatus (Biorad®, Mini Protean® 3, #165-3301). In general, 5 μl of 
protein samples were mixed with 10 μl of SDS gel-loading buffer. Bromophenolblue 
stained the stacking gel and the protein samples to support visually the loading of the 
samples. 5 μl protein ladder (several products of Thermo Fisher Scientific®: SM0671, 
SM0661, #26616) were also loaded in the gel to estimate the molecular weight of the 
proteins. Gelcode® Blue stain reagent (Thermo Fisher Scientific, #24590) served as 
Coomassie-blue staining to visualize the separated proteins in the gel and the procedure 
was done according to manufacture’s manual.  
 
2.17.2 Tris-glycerol based SDS-PAGE 
Modified separation gel, stacking gel, gel buffer and extra cathode and anode buffer (see 
3.1) were used in contrast to previous subchapter. The cathode buffer and anode buffer had 
to be filled in the appropriate reservoir ensuring no leaking between the both reservoirs 
occurred. All other aspects were performed according to the previous subchapter. This 
modified electrophoresis approach was only used in chapter 4.1.2.2 to improve the 
resolution of protein samples in SDS gels.  
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2.18 Sample preparation for SDS-PAGE under strongly reducing 
conditions 
 
This preparation was performed to disrupt protein homo-dimers in SDS-PAA gels. Protein 
samples were mixed with strongly reducing loading buffer in 1:1 ratio (see 3.1). The 
samples were heated at 65°C for 10 min and second 95°C incubation followed for 5 min. 
After the samples cooled down a centrifugation step (13,000 rpm, 2min, RT) and a SDS-
PAGE (see 2.17) followed.  
 
2.19 Removal of DNA out of purified protein samples 
 
The DNA had to be removed to exclude any protein-DNA interaction in SDS-gels. 
2.19.1 DNase I treatment 
The purified protein samples were dialyzed against 1x DNase reaction buffer to be 
compatible for DNase I treatment. Dialysis was performed according to manufacturer’s 
protocol (scienova™, xpress micro dialyzer 100 MWCO 12-14 kDa, #40784). Additionally 
a second dialysis step was done against 150 ml stirring 1xDNase reaction buffer for 2 h at 
RT to ensure a complete dialysis. DNase I (Thermo Fisher Scientific® #EN0521) was 
added to 100 μl of purified, dialyzed protein solution with final concentration of 0.05 U/μl. 
An incubation step at 4°C for 30 min and a second step at 37°C for 15 min activated the 
DNase I reaction. The addition of 2.5 mM EDTA and an incubation at 65°C for 10 min 
served as deactivation.  
 
2.19.2 Benzonase treatment 
The dialysis step was performed similar to the previous subchapter. The dialysis was 
performed against Benzonase reaction buffer. The dialysis was divided into two steps: the 
first step was 1 h 45 min long and done on ice followed by substituting the Benzonase 
reaction buffer and the second step was a 30 min long incubation at RT. Benzonase 
(Novagen®/EMD Millipore, Benzonase® Nuclease, #70746-4) was added to the dialyzed 
protein sample with a final concentration of 0.3 U/μl. The incubation step for Benzonase 
reaction was performed from 30 min to 4 h at 37°C with gentle shaking.  
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2.20 Detection of recombinant proteins by Western blot analysis 
 
A semi-dry Western blot (alternatively: Immunoblot) was performed to detect the KNL2 
variants by His tag and KNL2Cterm specific antibodies. The proteins were separated on a 
SDS-PAA gel and subsequently blotted on a protein-binding membrane (PVDF or 
nitrocellulose). Two slightly different approaches were applied.  
2.20.1 Western blot according Bjerrum and Schafer-Nielsen (1986) 
Procedure was executed according to Bjerrum and Schafer-Nielsen (1986) and manual of 
the PVDF membrane (GE healthcare biosciences®, Hybond-P PVDF membrane, rpn303F) 
with slight modifications. A PVDF membrane was used in all experiments as protein 
binding matrix except in the agarose based EMSA (see 2.22.1), in which a nitrocellulose 
membrane (GE healthcare, ECL nitrocellulose membrane, rpn203D) was chosen. Electro-
blotting was run with 140 mA per blotting stack for 1 h 15 min. However, voltage never 
exceeded 25 V to avoid damage of the blotting apparatus (BioRad®, Trans-Blot SD, #170-
3940). Schleicher & Schuell®´s (GE healthcare) GB005 was chosen as blotting paper. 
TBS buffer system (see 3.1, Protein transfer buffer) was used in all Western blot 
experiments. The incubation of the protein-binding membrane in blocking buffer was 
increased to 2 hours to decrease unspecific background signals. Antibodies were applied 
according to the related experiments. ‘Anti-His tag-HRP’ antibodies (monoclonal, mouse, 
HRP coupled, Miltenyi Biotec®, #130-092-785, 1:5000) was part of direct 
immunodetection of His tagged recombinant proteins in EMSA experiments (see 4.2.1). 
Two different pairs of primary and secondary antibodies were used in indirect 
immunodetection assays. Primary ‘anti-His tag’ (monoclonal, mouse; Sigma-Aldrich, 
#H1029, 1:100) and secondary ‘anti-mouse-IgG-HRP’ (polyclonal, rabbit, HRP-coupled; 
Sigma-Aldrich, #A9044, 1:500) antibodies were used for the detection of His tagged 
proteins in Western blots (see 2.20.2 & 4.1.4.2). The primary polyclonal rabbit antibodies 
against KNL2Cterm (‘anti-KNL2Cterm’, 1:1000, see 2.27) were detected by the secondary 
‘anti-rabbit-HRP’ (HRP coupled, donkey, GE healthcare, #NA934V, 1:5000) to 
characterize the KNL2 antibodies and the KNL2 SALK TDNA insertion line Arabidopsis 
plants (see 2.27 & 4.2.4.4). The incubation with primary antibodies and the antibodies for 
the direct immunodetection was performed ON at 4°C and the incubation of the secondary 
antibodies lasted 2h at RT. ECL reaction was done with BioRad® ImmunStar HRP 
Chemoluminescent kit (#170-5040) according to BioRad®´s manual to trigger the 
enzymatic, chemoluminescent reaction of the coupled HRP enzyme. GE healthcare´s 
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Hyperfilm ECL (#28906837) was chosen as chemoluminescent film, which detect the 
emitted light of the HRP reaction. Exposure time of film to the reaction depends on each 
experiment. Kodak®-GBX´s developer & replenisher (CAT 190 0984) and fixer & 
replenisher solution (CAT 190 2485) were used for developing the exposed 
chemoluminescent film in the dark room. Developing time of the film was 1min, followed 
by first washing step in water. Then, and fixation was done in 2 min followed by final 
washing step. 
 
2.20.2 Western blot according to Kyhse-Andersen (1984) 
This Western blot alternative protocol can help to overcome some blotting limitations of 
the first mentioned Western blot approach and it differed in the composition and usage of 
transfer buffers. The blotting stack was arranged from anode to cathode in following order: 
2 blotting papers soaked in western buffer III; 2 blotting papers and the PVDF membrane 
soaked in western buffer II and the gel from SDS-PAGE and 2 blotting papers soaked in 
western buffer I. The needed electric current was calculated by 0.8 mA per cm2 of 
membrane area. The remaining procedure resembled 2.20.1. This approach was used in the 
Western blot analysis of the recombinant protein (see 4.1.4.2).  
 
2.21 Protein identification by Mass spectrometry (MS) 
 
Certain bands of KNL2 variants in a SDS-PAA gel were analyzed by MS to verify the 
identity of these bands. Two spots per protein band were picked (with spotpicker of 
Biostep®; 1.5mm diameter) out of a Coomassie-stained SDS-PAGE gel (see 2.17). The 
pieces were separated and subsequently washed with 400 μl of MS wash solution followed 
by shaking for 30 min at RT. The samples were centrifuged down and supernatants were 
discarded. Gel pieces were dried by a vacuum concentrator for 15 min. 7.5 μl of MS 
digestion solution was added to each gel piece and the pieces were incubated for 5 h at 
37°C. 1 μl of 1% TFA was added, followed by a centrifugation step. The sample was 
incubated ON at 5°C. 0.5 μl of the sample was placed on the target plate (Bruker 
Daltonics, MTP AnchorChip™ 384 800um, # 209514) and dried partially. 1 μl of MS 
working solution was added and the remaining solution was evaporated. MALDI-TOF 
analysis was applied to identify the samples.  
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2.22 Protein-DNA binding analysis by Electrophoretic Mobility Shift 
Assay (EMSA) 
 
Two different EMSA approaches were chosen to study the DNA binding capability of the 
purified KNL2 variants (see 2.16.2) and PCR amplified DNA fragment cen180 (see 2.4). 
2.22.1 Agarose gel based EMSA  
The purified protein samples (see 2.16.2) were dialyzed against EMSA buffer 1 according 
to manufacturer’s protocol (scienova™, xpress micro dialyzer 100 MWCO 12-14 kDa, 
#40784) and their concentration was determined by Bradford method (see 2.15). The 
amplified cen180 sequence (see 2.4) was purified (see 2.5) and subsequently eluted in 
10 mM tris-HCl pH 7.5. The remaining compounds of EMSA buffer 1 were added to these 
DNA samples to achieve the same buffer conditions in DNA and protein samples. The 
DNA concentration was measured by nanodrop (see 2.7). The EMSA was performed 
according to Palecek et al. (1999) with some modifications. 0.5 μg of DNA and 0.5 μg of 
protein were used. After the combination of both binding partners the volume of the 
protein-DNA mixture was not increased to 20 μl to maintain the high DNA and protein 
concentration. For the formation of protein-DNA complex samples were incubated for 
30 min on ice. Then, 5 μl of DNA loading buffer was added to the mixture to enable the 
loading in 1% agarose gel, which was pre-stained with SYBR® safe (see 2.6). Capillary 
blotting was performed to transfer samples on the nitrocellulose membrane. The manual of 
Whatman®/Schleicher&Schuell Turbo™Blotter System (now: GE healthcare) was used 
with slight modifications to transfer the proteins from the agarose gel to a protein-binding 
nitrocellulose membrane (GE healthcare®, Hybond ECL nitrocellulose membrane, 
rpn203D). The initial denaturation step of the agarose gel was not needed to be performed. 
The agarose gel was shortly rinsed with dH2O, then, soaked in 20x SSC for 30 min and 
finally incubated in 6x SSC. The protein-binding membrane was rinsed with dH2O and 
incubated for 10 min in 6x SSC. The blotting stack consisted of following parts from the 
bottom to the top: 20 dry sheets of GB004 (Whatman®/GE healthcare), 4 dry sheets of 
hybond blotting paper (GE healthcare, rpn6101M; thickness 0.39 mm), one 6x SSC soaked 
sheet of hybond blotting paper, the prepared membrane, the prepared gel and three 10x 
SSC soaked sheets of hybond blotting paper. The assembled stack was connected with a 
10x SSC soaked ´buffer wick´ to the 10x SSC filled ‘buffer tray’ of the Turbo™Blotter 
System. The blotting was performed over 4h 15 min at RT. The membrane was washed in 
2x SSC for 5 min after blotting, followed by second washing step in 1x TBS for 5 min. A 
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Western blot (see 2.20) was performed afterwards to identify blotted proteins on the 
nitrocellulose membrane.  
2.22.2 PAA gel based EMSA  
The recommendation of Hellman and Fried (2007) were followed. Purified protein samples 
were dialyzed similar to previous subchapter. EMSA refolding buffer was used in the first 
dialysis step and the second step was performed with EMSA buffer 2. PCR of the cen180 
fragment was done according to the previous subchapter. The cen180 fragments were 
eluted with EMSA buffer 2 at the end of the PCR sample purification (see 2.5). Protein and 
DNA concentration measurements were also performed according to 2.22.1. The volume 
for 4 pmol of cen180 or KNL2 variants were calculated by Promega®´s Biomath in silico 
tool (http://www.promega.de/resources/tools/biomath-calculators) based on the measured 
DNA or protein concentration. An native 7% or 8% PAA gel (see 4.2.1) was cast 
according to Green and Sambrook (2012) with 0.5x TBE. The pre-electrophoresis was 
performed with 70 V or 10 mA per gel and without the samples in an ice cooled 
electrophoresis chamber to check the property of the gel. KNL2Cterm and cen180 were 
mixed according to distinct ratios ranging from 1:1 to 1:5 (see 4.2.1). The DNA competitor 
poly-deoxyinosinic-deoxycytidylic acid sodium salt (poly dI/dC; Affymetrix, #20539) may 
be added in concentration ranging from 3-100 μg/μl to verify DNA binding capability of 
the protein. 1 volume of EMSA additives buffer was added to 10 volumes of DNA-protein 
mixtures to enable the loading of the samples into the gels and to stabilize the protein-
DNA complexes. The electrophoresis was done with 70 V or 10 mA per gel about 1 h with 
ice cooling. DNA was stained after electrophoresis with SYBR® safe staining (life 
technologies®, S33102) to visualize the DNA fragments. The SDS-loading of the proteins 
was performed according to Granger-Schnarr et al. (1988) to enable the proteins to be 
transferred from the native PAA gel to the PVDF membrane. A Western blot (see 2.20.1) 
visualized KNL2 variant proteins. 
 
2.23 Protein interaction studies by Bimolecular Fluorescence 
Complementation (BiFC) 
 
The interaction of two proteins, which are fused with complementary ‘split’ parts of GFP 
or GFP variants (YFP/EYFP), can be observed in Nicotiana benthamiana plants transiently 
transformed by Agrobacterium tumefaciens carrying vector for expression of fusion 
proteins. Overnight cultures were prepared with 5 ml of YEB medium containing 
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kanamycin (50 μg/ml) and rifampicillin (50 μg/ml) and this liquid medium was inoculated 
by glycerol stocks of Agrobacterium (strain GV3101) cultures carrying the vectors 
pSPYCE-35s or pSPYNE-35s (Prof. Dr. Klaus Harter, University of Cologne) with coding 
inserts of split YFP fused to KNL2, KNL2Cterm and CenH3. Incubation of cultures was 
performed at 28°C with shaking at 180-200 rpm. Overnight cultures were centrifuged 
down (5000 rpm, 10 min, RT) and the pellets were resuspended in AIM with freshly added 
acetosyringone (final concentration 0.15 mM). AIM plus acetosyringone were added until 
the OD600 values of the cell suspensions were diluted to 0.8. The cultures were combined 
according to following scheme: 2 volumes of the culture with compatible N-terminal part 
of split YFP, 2 volumes of the culture with compatible C-terminal part of split YFP and 1 
volume of HcPro vector containing culture. The co-infiltration of HcPro supported the 
transient expression of both fusion-constructs. The mixed cultures were incubated at RT 
for 1 h with moderate shaking at 50 rpm. Nicotiana benthamiana leaves were infiltrated 
with the cultures by needleless syringes (Henke Sass Wolf, Soft Ject®, #5010.200V0). 
Plants shall be protected for one day against intensive light after infiltration. Infiltrated 
leaves were analyzed after two or three days under an epifluorescence microscope (Zeiss, 
Axiophot equipped with a 100x/1.45 α plan-fluar objective and a Sony® DXC-950P color 
camera). Appropriate excitation and emission filter were used to visualize YFP signals. 
Some pictures were acquired by applying Differential Interference Contrast (DIC). The 
lower epidermis was extracted to exert DIC. 
 
2.24 In silico co-expression analysis 
The program CORNET (https://cornet.psb.ugent.be/main/tool) was chosen for analysing 
the co-expression of different candidate genes (see 4.2.3.1). Predefined groups of micro 
array experiments were used and the standard setting was changed by taking the “pair-wise 
correlations” option to get a comprehensive overview about the candidate genes. All 
available microarray data were selected. 
 
2.25 Kinase assay 
 
The cDNA Aurora kinase 3 was inserted into pDEST566 expression vector (Life 
technologies®). Subsequently recombinant Aurora kinase 3 was expressed in E. coli BL21 
strain cells and purified against its MBP-tag with amylase resin (New England Biolabs, 
#E8021). The Aurora kinase 3 and KNL2 variants were dialyzed against 1x kinase assay 
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buffer (compare 2.26). The kinase assay was composed of following ingredients: 1 μl of 
ATP, 1 μl of ATP-P32 (Hartmann Analytic, SRP-301), 1 μl of 10x kinase assay buffer, 
1 μl of dH2O, 8 μl of dialyzed KNL2 variant solution and 8 μl of dialyzed Aurora kinase 3 
solution. The kinase reaction was carried out for 1.5 h at 30°C. 6 μl of protein loading 
buffer (Carl Roth®, 4x Roti®-Load 2, K930.1) was added and the samples were incubated 
at 95°C for 5 min to prepare them for loading on SDS-PAA gels. After the SDS-PAGE the 
gels were stained with Coomassie (see 2.17). The stained gels were incubated in 3% 
glycerin for 30 min to prepare them for the subsequent drying procedure. The gels were 
covered in Cellophane-membranes and subsequently dried (compare Biorad, GelAirDrying 
system, 165-1771) to increase the phosphorylation signal. The dried gels were analyses 
with phospho-imager (Fuji, FLA 5000) after one hour exposure. 
 
2.26 Refolding of purified protein samples 
 
Refolding of purified KNL2Cterm (see 2.16.2) was done according to manufacturer’s 
protocol (scienova™, xpress micro dialyzer 100 MWCO 12-14 kDa, # 40784) to remove 
urea from the buffer and achieve buffer conditions, which were suitable for injection in 
rabbit. The procedure was separated in three steps. The first dialysis step was performed 
over 2.5 h against 1300 μl refolding buffer at RT with changing the refolding buffer every 
30 min. In the second step, the sample was dialyzed over 3 h 15 min against 1300 μl rabbit 
injection buffer at 4°C. The buffer was changed frequently every 45 min. In the third step, 
the sample was dialyzed over night against rabbit injection buffer.  
 
2.27 Production of polyclonal rabbit antibodies  
 
Two rabbits were injected with 500 μl of Freund´s complete or incomplete adjuvant (BD 
DIFCO; #263810 = complete, #263910 = incomplete adjuvant) and 500 μl of 0.5 – 1 μg/μl 
purified (see 2.16.2) and refolded (see 2.26) KNL2Cterm protein three times to trigger an 
immune response. First injection was done with complete adjuvant and the two 
subsequently following injections were performed with incomplete adjuvant. Second 
injections were performed 4 weeks after the firsts and one week later the third injections 
was done. One week after the third injection the blood samples were taken by from ears of 
the rabbits and about 2 weeks later the rabbits were sacrifice and the antiserum was taken.  
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2.28 Antibody analysis by Enzyme Linked Immunosorbent Assay 
(ELISA) 
 
The ELISA was performed to control the immune response of the rabbits against the 
antigen KNL2Cterm. Nunc® microplates (Th. Geyer, #7650589) were prepared with 7 ml 
of 1x PBS plus 10 μg/ml of antigen. The microplates were incubated overnight at RT. The 
supernatant was removed, 200 μl of ELISA blocking buffer per well were added and the 
plates were incubated for 2 h at RT. 100 μl of diluted (1:104-1:107) antisera were added per 
well followed by an incubation step for 1-1.5 h at RT. The microplates were washed five 
times with PBS-T. The secondary antibodies (anti-rabbit, IgG, alkaline phosphatase 
coupled; Sigma-Aldrich, #A3812, 1:2000) was added and the microplates were incubated 
for 1 h at RT. 15 ml of ELISA detection solution was added to the microplates followed by 
an incubation step at 37°C for 10 min. The microplates were read out with an ELISA 
reader (Tecan, Infinite 200). 
 
2.29 Purification of antiserum  
 
The antisera were treated with two different methods, protein A purification and 
ammonium sulfate precipitation, to remove non-protein parts of the antiserum.  
2.29.1 Purification of IgG antibodies using protein A 
The protein A-agarose purification was performed with beads of Roche Applied Science 
(#1 719 408) according to manufactures protocol to isolate IgG isotype antibodies with 
high affinity. Other antibody isotypes (IgA, IgD, IgE and IgM) were minor targets of the 
purification. The eluted antibodies were dialyzed (Carl Roth, 27/32, 12-14000 MWCO) 
against 1xPBS for 1.5 d at 4°C. 
2.29.2 Ammonium sulfate precipitation 
Following protocol was used for the precipitation of all proteins in the antisera. 1 volume 
of antiserum and 1 volume of saturated ammonium sulfate solution were mixed and 
subsequently shaken at 4°C. The solution was centrifuged down at 4000 rpm for 10 min at 
4°C. The pellet was dissolved with PBS (usually 10 ml) until the solution got clear and the 
sample was dialyzed against PBS (see 2.29.1). 
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2.30 Immunostaining with anti-KNL2Cterm antibodies 
 
Arabidopsis thaliana flower buds or root tips were used as material for the anti-
KNL2Cterm antibodies immunostaining treatment to verify these antibodies and analyze 
the sub-cellular localization of KNL2.  
2.30.1 Immunostaining of Arabidopsis flower buds 
Flower buds were cut from the plants and transferred into MTSB buffer followed by 
shaking. Fresh immunostaining fixation buffer replaced MTSB buffer. Mild vacuum was 
applied for 4-5 min terms for total 20 min to let the MTSB buffer infiltrate the plant 
material. Flower buds were washed 2-3 times with MTSB buffer and 150 μl of 
immunostaining enzyme mix was added. The enzymatic reaction took place for 20-40 min 
at 37°C. Another washing step with MTSB buffer was performed. The anthers of the 
flower buds were separated under a stereomicroscope. The anthers of three flower buds 
were placed on each slide. Cover slips were laid over the anthers’ suspension and the 
anthers were squashed with moderate strength to enable the removal of cytoplasma. The 
edges of the cover slip were marked by scratching the slide surface, then, the slides were 
frozen in liquid nitrogen and the cover slips were removed. The slides were stored shortly 
in MTSB buffer and subsequently 60 μl of immunostaining blocking buffer were dropped 
directly onto the sample area. The buffer was covered with Parafilm® (Menasha WI 
54952) and incubated for one hour at RT in humidity chamber, then, 40 μl of primary 
antibodies were added. Primary antibodies were rabbit antiserum immunized by 
KNL2Cterm (1:500), protein A purified ’anti-KNL2Cterm’ (1:500) or ‘anti-GFP’ dylight® 
488 (monoclonal, mouse; Rockland Immunochemicals, 200-341-215, 1:50). Antibodies 
were diluted in immunostaining blocking buffer. Slides were covered with Parafilm® and 
stored overnight at 4°C in humidity chamber. Next day slides were washed in MTSB 
buffer times for 10 min each and subsequently 40 μl of secondary ‘anti-rabbit-rhodamine’ 
antibodies (goat, polyclonal, rhodamine coupled; dianova®, 111-295-144, 1:200) was 
added and samples were incubated for 1 h in humidity chamber. A repetition of the 
previous washing step followed. To stain chromatin 8 μl of DAPI solution (10 μg/ml DAPI 
diluted in Vectashield®; Vector Laboratories, #H-1000) was added per slide and the 
samples were covered by a cover slip. The slides were dried with drying paper and they 
were analyzed by using an epifluorescence microscope (see 2.23). The microscope was 
integrated into a 3D digital optical microscope system (Confovis). Structured Illumination 
Microscopy (SIM) was applied to achieve resolution at 100 nm by using an Elyra 
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microscope (Zeiss) equipped with a C-Apochromat 63x/1.40 W Korr objective. Lasers 
were used to excite DAPI (405 nm), dylight® 488 (488 nm) and rhodamine (561 nm). 
2.30.2 Immunostaining of Arabidopsis roots tips 
The procedure for the preparation of root tips was similar to the procedure of flower buds 
preparation (see 2.30.1) with few modifications. Arabidopsis thaliana seedlings were 
grown on vertically orientated, wet tissue paper over three days and subsequently used for 
immunostaining. After enzyme treatment the root tips were separated from seedlings and 
10 root tips were taken per slide. The squashing was performed more carefully.  
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3 Materials 
 
3.1 Media 
 
AIM: 10 mM MgCl2, 5mM MES, pH 5.3-5.5 
Anode buffer (10x): 2 M tris, pH 8.9 
Bacterial lysis buffer: 50 mM tris-HCl, 500 mM NaCl, 15% (v/v) glycerol, pH 8 
Benzonase reaction buffer: 50 mM tris-HCl, 1 mM MgCl2, pH 8 
Blocking buffer: 1x TBS, 0.1% [v/v] Tween 20, 5% [w/v] dried skimmed milk 
Cathode buffer (5x): 500 mM tris, 500 mM tricine, 0.5% [v/v] SDS 
DNA loading buffer: 50% [v/v] glycerol, 1 mM EDTA, 0.4% [w/v] bromophenolblue 
DNase reaction buffer (1x): 10 mM tris-HCl, 2.5 mM MgCl2, 1 mM CaCl2, pH 7.5 
ELISA blocking buffer: 1x PBS, 3% BSA, 0.5% Tween 20 
ELISA detection buffer: 15 ml 99% diethylamine + 10 g/l MgCl2, pH 9.6; add 1 pill of 4- 
Nitrophenyl Phosphate Disodium Salt Hexahydrate (Sigma-Aldrich, N2765) 
EMSA additives buffer: 10 mM tris-HCl, 50 mM KCl, 1 mM DTT, 0.01% [v/v] Triton 
X-100, 44% [v/v] glycerol, 110 μg/μl BSA, 0.4% [w/v] bromophenolblue, pH 7.5 
EMSA buffer 1: 5 mM tris-HCl, 50 mM KCl, 0.01% [v/v] Triton X-100, pH 7.5 
EMSA buffer 2: 10 mM tris-HCl, 50 mM KCl, 1 mM DTT, 0.01% [v/v] Triton X-100, 0.5 
M/0.19 M /no urea (see 4.2.1), pH 7.5 
EMSA refolding buffer: 1 M urea, 10 mM tris-HCl, 50 mM KCl, 1 mM DTT, 0.01% 
[v/v] Triton X-100, pH 7.5 
GuHCl pH 8 buffer: 6 M Guanidinium chloride, 20 mM NaH2PO4, 300 mM NaCl, 5 mM 
β-mercaptoethanol, 10% [v/v] glycerol, 0.5% [v/v] Triton X-100, pH 8 
Immunostaining antibody buffer: 1% BSA in MTSB buffer 
Immunostaining blocking buffer: 8 % BSA & 0.1% Triton X-100 in MTSB buffer 
Immunostaining enzyme mix: 2.5% pectinase (Sigma-Aldrich® 13789-10G) & 2.5% 
cellulase (Sigma-Aldrich® C-1184) & 2.5% pektolyase (Sigma-Aldrich® P3026-1G) in 
MTSB buffer 
Immunostaining fixation buffer: 4% paraformaldehyde in MTSB buffer 
Kinase assay buffer (1x): 10 mM tris, 50 mM KCl, 2 mM MgCl, 1 mM β-mercapto-
ethanol, pH 7.4 
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MS digestion solution: 10 ng/μl trypsin (Promega, V511A; dissolved in 50mM acetic 
acid), ≈5 mM ammonium bicarbonate (exactly 4,75 mM), ≈5% acetonitril (exactly 4,75%) 
MS wash solution: 10 mM ammonium bicarbonate & 50% [v/v] acetonitrile dissolved in 
18 MΩ-H2O 
MS working solution: 0.7 mg/ml HCCA dissolved in 90% acetonitril + 1% TFA + 
phosphate  
MTSB buffer: 50 mM PIPES, 5 mM MgS04, 5 mM EGTA, pH 6.9 
LB media: 10 g/l tryptone, 5 g/l yeast extract, 10 g/l NaCl 
PBS (1x): 8.01 g/l NaCl, 0.2 g/l KCl, 1.78 g/l Na2HPO4 ∙ H2O, pH 7.4 
PBS-T: 1x PBS, 0.5% Tween 20 
PCR mastermix: 14.3 μl dH2O, 5 μl 5x PCR buffer (Promega 5x Green GoTag® reaction 
buffer, M791A), 2 μl forward primer (10 μM) (see 3.2), 2 μl reverse primer (10 μM), 
0.5 μl dNTP´s (10 mM), 0.2 μl Taq-Polymerase (Promega, GoTag® DNA polymerase, 
#M830C – for analysis; Takara Bio, PrimeStar®, #R010A – for generation of coding 
sequence in Gateway®) 
Protein transfer buffer (according to Bjerrum and Schafer-Nielsen (1986)): 48 mM tris, 
39 mM glycine, 20% [v/v] methanol 
Rabbit injection buffer: 25 mM urea, 120 mM NaCl, 10 mM Na2HPO4, 1 mM DTT, 
0.01% Triton X-100, pH 7.5 
Refolding buffer: 1 M urea, 280 mM NaCl, 10 mM Na2HPO4, 2 mM DTT, 0.01% Triton 
X-100, pH 7.5 
SDS gel-loading buffer: 56 mM Na2CO3, 56 mM DTT, 2% [v/v] SDS, 12% [w/v] sucrose 
SOC media: 0.5% [w/v] yeast extract, 2% [w/v] tryptone, 10 mM NaCl, 2.5 mM KCl, 
10 mM MgCl2, 10 mM MgSO4, 20 mM glucose (add after autoclaving); Sterilize with 0.2 
μm sterile filter 
SSC (20x): 3 M NaCl, 300 mM trisodium citrate 
Strongly reducing loading buffer: 50 mM glycine, 2% [v/v] SDS, 10% [v/v] glycerol, 
5% [v/v] β-mercaptoethanol, 50 mM DTT, pH 2.8 
TE (1x): 10 mM tris, 1 mM EDTA, pH 8.0 
TBE (1x): 90 mM tris, 90 mM borate acid, 2 mM EDTA 
TBS: 50 mM tris, 150 mM NaCl 
Tris-glycerol gel buffer: 3 M tris, 0.3% [v/v] SDS, pH 8.45 
Tris-glycerol separation gel: 4.88 ml 50% [v/v] acrylamide mix, 8 ml tris-glycerol gel 
buffer, 8 ml 50% [v/v] glycerol, 3.12 ml dH2O, 150 μl 10% [v/v] APS, 15 μl TEMED 
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Tris-glycerol stacking gel: 1 ml 50% [v/v] acrylamide mix, 3 ml tris-glycerol gel buffer, 8 
ml dH2O, tip of bromophenolblue, 160μl 10% [v/v] APS, 16μl TEMED 
Tris-glycine electrophoresis buffer (5x): 25 mM tris, 250 mM glycine, 0.1% [v/v] SDS 
Urea containing buffer with pH 8/pH 6/pH 5.3/pH 4/pH 2.8: 8 M urea, 20 mM 
NaH2PO4 /(for pH2.8: 20 mM citric acid), 300 mM NaCl, 5 mM β-mercaptoethanol, 10% 
[v/v] glycerol, 0.5%/0.01% [v/v] Triton X-100*, pH 8/pH 6/pH 5.3/pH 4/pH 2.8 
(*TritonX-100 concentration depends on the experiment: 0.5% for analytical western for 
characterization of protein purification (see 2.19) and 0.01% for EMSA (see 2.22), 
antibody production (see 2.27) and kinase assay (see 2.25)) 
Western buffer I: 40 mM aminocaproic acid, 25 mM tris, 20% [v/v] methanol 
Western buffer II: 25 mM tris, 20% [v/v] methanol 
Western buffer III: 300 mM tris, 20% [v/v] methanol 
YEB: 5 g/l beef extract, 1 g/l yeast extract, 5 g/l peptone, 5 g/l sucrose, 0.5 g/l MgCl2 
 
3.2 PCR program and primers 
 
The following PCR schedules refer to the generation of inserts for the entry vector 
pDONR221 and to the validation of the expression vectors (see 2.1& 4.1). The elongation 
step of the PCR program was adjusted to the different size of the inserted KNL2 variants 
cDNA. The primers for these inserts contain sequences of Gateway® recombinase sites, as 
well sequences of the recombinant KNL2 variants. The start codon of the coding sequences 
and the end of the cDNA are marked.  
 
PCR program: 
94°C for 5 min (initiation step); 30 cycles of: 94°C for 30 s, 55°C for 30 s, 72°C for 111 s 
(KNL2)/69 s (KNL2Nterm)/47 s (KNL2Cterm); 4°C (final hold) 
 
Primers: 
KNL2attB1 
5’-GGG GAC AAG TTT GTA CAA AAA AGC AGG CTT CAT GAC GGA ACC AAA 
TCT CGA C-3’ 
KNL2attB2 
5’-GGG GAC CAC TTT GTA CAA GAA AGC TGG GTC TTT GAT TTT CAA GTT 
TCT TCG-3’ 
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KNL2intattB1 
5’-GGG GAC AAG TTT GTA CAA AAA AGC AGG CTT CAT GAA TTA CTC TGG 
GAC GAA AG-3’ 
KNL2intattB2 
5’-GGG GAC CAC TTT GTA CAA GAA AGC TGG GTC GGG ATC TAC TAC ATT 
GTC GTC-3’ 
 
Primer pairs for each KNL2 variant 
KNL2 variant Forward primer Reverse primer 
KNL2 KNL2attB1 KNL2attB2 
KNL2Nterm KNL2attB1 KNL2intattB1 
KNL2Cterm KNL2intattB1 KNL2attB2 
 
The following PCR schedule is applied in the generation of cen180 products (see 2.4). The 
cen180 fragments were used in EMSA experiments (see 4.2.1). 
 
PCR program: 
94°C for 5 min (initiation step); 30 cycles of: 94°C for 20 s, 60 °C for 30 s, 72°C for 1 min, 
4°C (final hold) 
 
Primers: 
cen180forward 
5’-GGT TAG TGT TTT GGA GTC GAA TAT G-3’ 
cen180reverse 
5’-TTG CTT CTC AAA GAT TTC ATG GT-3’  
 
These primers were used for DNA sequencing (see 2.9 & 4.1.1). 
Primers: 
pET-T7Pro  
5’-TAA TAC GAC TCA CTA TAG GG-3’ 
pET-T7Ter   
5’-GCT AGT TAT TGC GCG G-3’ 
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3.3 Vectors 
 
pDEST17      Life technologies; Carlsbad, CA, USA 
pDONR221      Life technologies; Carlsbad, CA, USA 
pSPYCE-35s      Walter et al. (2004) 
pSPYNE-35s      Walter et al. (2004) 
 
3.4 Organisms 
 
3.4.1 Bacteria 
Agrobacterium tumefaciens GV3101  IPK-Gatersleben 
Escherichia coli DH5α    IPK-Gatersleben 
Escherichia coli BL21    IPK-Gatersleben 
 
3.4.2 Plants 
Arabidopsis thaliana Columbia-0   IPK-Gatersleben 
Nicotiana benthamiana    IPK-Gatersleben 
 
3.5 Chemicals, enzymes and kits 
 
Affymetrix (Santa Clara, CA, USA) DNA competitor  
BD DIFCO (Franklin Lakes, NJ, USA) Freund´s Adjuvant 
Bio-Nobile Oy (Bio-Nobile Oy, Finland) magnetic Ni2+-NTA  
  agarose beads 
BioRad (Hercules, CA, USA) bradford dye,  
  HRP Chemoluminescent kit 
Carl Roth (Karlsruhe, Germany) several chemicals for media,  
   protein loading buffer 
Dianova (Hamburg, Germany) anti-rabbit antibodies 
EMD millipore (Billerica, MA, USA) Benzonase 
GE healthcare (Little Chalfont, UK) anti-rabbit antibodies  
Hartmann Analytic (Braunschweig, Germany) radioactive labeled ATP 
Kodak (Rochester, NY, US) film developer and fixer 
                                                 
 alternatively: Rhizobium radiobacter 
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Life technologies (Carlsbad, CA, USA) enzymes and vectors for  
  Gateway cloning, agarose,  
  SYBR safe DNA staining 
Macherey-Nagel (Düren, Germany) Ni2+-NTA agarose beads 
Miltenyi Biotec (B.-Gladbach, Germany) anti-His tag antibodies 
New England Biolabs (Ipswich, MA, USA) amylase resin 
Promega (Fitchburg, WI, USA) Tag-Polymerase, trypsin 
QIAGEN (Venlo, Netherlands) kits: miniprep, PCR  
  purification, genomic plant  
  DNA extraction; Ni2+-NTA  
  agarose beads 
Roche Applied Science (Penzberg, Germany) Protein A beads 
Rockland Immunochemicals (Gilbertsville, PA, USA) anti-GFP antibodies 
Serva Electrophoresis (Heidelberg, Germany) several chemicals for media 
Sigma-Aldrich (St. Louis, MO, USA) several chemicals for media,  
  antibodies (anti-His tag, anti- 
  mouse, anti-rabbit), alkaline  
  phosphatase substrate,  
  cell wall digesting enzymes 
Takara Bio (Seta, Japan) Tag-Polymerase 
Thermo Fisher Scientific (Waltham, MA, USA) DNA gel marker,  
  protein latter, Coomassie  
  staining, DNase I 
Vector Laboratories (Burlingame, CA, USA) anti-fade additive in  
  fluorescence microscopy 
 
3.6 Laboratory tools 
 
BioRad  (Hercules, CA, USA) PCR machine, photometer,  
   electrophoresis apparatus, blotting  
   apparatus 
Biostep (Jahnsdorf, Germany) gel spot picker 
Bruker Daltonics (Billerica, MA, USA) MS target plate 
Carl Roth (Karlsruhe, Germany) dialysis tubing 
EMD millipore (Billerica, MA, USA) nitrocellulose filter membrane 
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Eppendorf (Hamburg, Germany) photometer 
Equi Bio (Ashford, UK) electroporation machine  
  (Easy Jet prima) 
Fuji (Tokyo, Japan) phospho-imager 
GE healthcare (Little Chalfont, UK) blotting membrane, capillary blotting  
  system, blotting membrane, protein- 
  binding membranes,  
  chemoluminescent film 
Henke Sass Wolf (Tuttlingen, Germany) needleless syringes 
Menesha (Menasha, WI, USA) Parafilm 
prqlab (Erlangen, Germany) nanodrop machine 
Retsch (Haan, Germany) tissue disruptor 
Scienova (Jena, Germany) dialysis apparatus 
Sonics & Materials (Newtown, CT, USA) sonicator 
Syngene (Cambridge, UK) trans-illuminator  
Tecan (Männedorf, Switzerland) ELISA reader 
Th. Geyer (Renningen, Germany) microplates  
Zeiss (Oberkochen, Germany) epifluorescence microscope,  
  ELYRA microscope 
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4 Results 
 
4.1 In vitro expression of KNL2 
 
4.1.1 Generation and validation of the expression vectors 
The KNL2 protein and its N-terminal and C-terminal part (=KNL2 variants) were 
expressed in E. coli to characterize this protein with several approaches (see 1.7). The 
cDNA of the three KNL2 variants generated by a RT-PCR reaction using total RNA extract 
form flower buds of Arabidopsis thaliana (Lermontova et al., 2013) were cloned into 
Gateway compatible vector pDONR221 and subsequently subcloned into pDEST17 vector 
for protein expression (Supplemental Figure 1, see 2.1). 
The presence of the cDNA inserts of expected size inside the expression vector was 
confirmed by PCR (Figure 1 & Table 1, see 2.3 & 2.4) using flanking primers of the inserts 
(see 3.2). Subsequently the inserts were validated by sequencing* (Supplemental Figure 2-
4, see 2.9). Vectors with correct cDNA insertions in-frame with translation start were 
selected for protein expression.  
 
4.1.2 Production of recombinant KNL2 variants 
4.1.2.1 Analysis of expression of recombinant KNL2 variants in total 
protein E. coli cell extract 
KNL2 expression vectors were transformed into E. coli BL-21 strain (see 2.2) to express 
recombinant protein. Protein expression of KNL2 variants was induced by IPTG in the 
transformed liquid cultures (see 2.11). Protein extracts were analyzed by SDS-PAGE (see 
2.12 & 2.17) with subsequent Coomassie staining of the gel. Additional bands were 
detected in extracts of IPTG induced cell cultures, in contrast to extracts of uninduced cell 
cultures (Figure 2). A strong protein band above 40 kDa was observed in the protein 
extract of bacteria expressing the recombinant KNL2Cterm, additionally a protein band 
below 70 kDa in extracts of bacteria expressing KNL2Nterm and another above 100 kDa 
in extracts of bacteria expressing KNL2 extracts were visible. 
                                                 
* In cooperation with IPK Gatersleben 
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Figure 1: Amplified PCR 
products with the coding 
sequences of the three 
recombinant KNL2 variants were 
separated on a 1% agarose gel. A 
distinct ladder of bands appeared 
corresponding to the different 
sizes of cDNA insertions. 
 
 
 
 
 
Table 1: The expected sizes of the PCR products (Supplemental Figure 1) related to Figure 1 are shown. 
KNL2 variant Expected sizes (in bp) 
KNL2 1855 
KNL2N-term 1147 
KNL2C-term 769 
 
 
Figure 2: The protein extracts 
of IPTG induced cell cultures, 
which were expressing one of 
the KNL2 variants, were 
loaded on a 12% SDS-PAA 
gel. Three distinct bands 
appear. The KNL2Cterm band 
show higher intensity. 
 
 
 
 
 
 
 
4.1.2.2 Analysis of solubility of recombinant KNL2 variants 
A solubility test was performed to develop a strategy for purification of the recombinant 
KNL2 protein variants. For this purpose two protocols were used (see 2.13). The outcome 
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of both approaches was similar. Therefore, the results are shown only for the lab-own 
protocol. The tris-glycerol based gel electrophoresis (see 2.17.2) was used for this 
approach. The resolution of the tris-glycerol based gels was comparable to the tris-glycine 
based ones. The band (see 4.1.2.1) for KNL2 in the total protein extract was visible above 
100 kDa and appears also in the insoluble fraction (Figure 3) of this assay. The protein 
band for KNL2Nterm below 70 kDa was present in the soluble and insoluble fraction. No 
distinct bands were found in the fraction of E. coli extract expressing KNL2Cterm. The 
band scheme of KNL2Cterm extracts resembled the total extract of non-induced E. coli 
cells (data not shown). We suggest experimental bias was the reason for this phenomenon.  
 
 
Figure 3: Soluble (green arrowed lanes) and insoluble fractions (violet arrowed lanes) of the solubility assay 
(see 2.13) were loaded on a 12% SDS-PAA gel. Bands marked by the red frame indicate expressed 
recombinant KNL2 or KNL2Nterm protein.  
 
4.1.3 Purification of recombinant KNL2 variants 
Since, the main part of the KNL2 variants was present in insoluble fraction, a denaturating 
purification conditions were used. Two different purification protocols were performed 
(see 2.16). However, only the Ni2+-NTA batch purification allowed to purified sufficient 
amount of recombinant protein (data of QuickPick™ experiments are not shown). Elution 
fractions of the batch purification together with total protein extract of the induced cultures 
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(see 4.1.2.1) were loaded on a PAA gel (see 2.17.2). Already described bands (Figure 2) of 
the KNL2 variants were present in samples before (blue arrow labeled) and after 
purification (orange arrow labeled) (Figure 4). Three bands with already observed pattern 
were identified for the three KNL2 variants: the 110 kDa band for KNL2, the 65 kDa band 
for KNL2Nterm and the 38 kDa band for KNL2Cterm (Figure 4). There were additional 
bands below these ‘designated main protein bands’ in the fractions of the purified protein. 
These bands were characterized in chapter 4.1.4.2.  
 
 
Figure 4: Purified (blue arrowed lanes) and total protein extracts (see 2.12) of induced cultures (orange 
arrowed lanes) were loaded on a 12% SDS-PAA gel. Designated bands are marked by the red frame 
indicating expression of recombinant KNL2 variants.  
 
4.1.4 Validation of purified proteins 
4.1.4.1 Validation by molecular weight and the molecular weight 
discrepancy 
A correct match between expected and observed molecular weight of the designated bands 
of the expressed protein are a good hint for the specific expression. Unfortunately that 
could not be observed for KNL2 and KNL2Nterm (Table 2). KNL2Cterm showed almost a 
match. However, this observation could not be repeated in all experiments (Figure 2, 
Figure 4 & Supplemental Figure 5-7). There might be some problems in the execution of 
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the SDS-PAGE. A discrepancy in molecular weight could be induced by: 1) homo-
dimerization, which should leads to a doubled molecular weight, 2) post-translational 
modification, which should shifts the molecular weight slightly depending on the 
modification and 3) DNA-binding (see 1.7), which can lead to shift depending on the 
DNA-protein complex in denaturating PAA gels. Homo-dimerization and DNA-binding of 
the KNL2 variants were analyzed subsequently. However, no suggestion could be proven 
experimentally. Therefore, other mechanism or experimental bias may be the underlying 
reason for molecular weight discrepancy. 
 
Table 2: The expected molecular weights of the recombinant KNL2 variants were compared with the 
estimated weights of the observed designated bands in the SDS-PAA gel of the purification analysis (Figure 
4). The expected molecular weights were calculated from the cDNA sequence (Supplemental Figure 1) by 
using in silico translation (http://web.expasy.org/translate/) and subsequently the translated amino acid 
sequences served for as input for the calculation of the molecular weight 
(http://web.expasy.org/compute_pi/). The ratio of observed to expected molecular weights showed high 
difference for KNL2 and KNL2Nterm to KNL2Cterm.  
Protein Expected molecular 
weight (in kDa) 
Observed molecular 
weight in (kDa) 
Ratio 
KNL2 72 ≈ 110 153% 
KNL2Nterm 46 ≈ 65 141% 
KNL2Cterm 33 ≈ 38 115% 
 
4.1.4.1.1 The molecular weight of KNL2 variants in PAA gels is not 
changed due to formation homo-dimers 
Two different methods were applied to check the hypothesis, that homo-dimerization 
impacts PAA gel mobility of the KNL2 variants: Strong reducing treatment of the purified 
KNL2 samples (see 2.18), which should led to disruption of disulfide-bridges based homo-
dimers in vitro, and a BiFC in vivo assay (see 2.23). Within the BiFC assay constructs 
containing KNL2 and KNL2Cterm fused with two complementary parts of YFP separately 
were transiently expressed in tobacco (Nicotiana benthamiana). Restoring of a functional 
YFP protein was expected only in case of formation of KNL2 or KNL2Cterm homo-
dimers. However, no fluorescence could be observed (Supplemental Table 1). This 
suggests that KNL2 variants do not form homo-dimers. Also, the band pattern did not 
change through the strong reducing treatment (Supplemental Figure 5) in comparison to 
chapter 4.1.3. Both assays showed no evidence for homo-dimerization. 
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4.1.4.1.2 The molecular weight of KNL2 variants in PAA gels is likely 
not influenced by protein-DNA interaction  
The verification of the hypothesis, which assumes a protein-DNA complex was responsible 
for the molecular weight discrepancy in PAA gels (see 4.1.4.1), was done by the treatment 
of the protein samples with the enzymes DNase I or Benzonase (see 2.19). These enzymes 
should digest any DNA in the samples. If there were a shift caused by DNA binding, this 
effect should disappear after the enzymatic reaction. The band patterns of the KNL2 
proteins changed neither by DNase I nor by Benzonase treatment (Supplemental Figure 5 
& 6).  
4.1.4.2 Anti-His tag antibodies and mass spectrometry verify main bands of 
SDS gels as KNL2 protein variants and showed truncated products 
Two methods were chosen to verify the identity of designated bands of the KNL2 variants 
(see 4.1.4.1). 
A Western blot was applied (see 2.21) to detect all proteins, which carry a His tag, by anti-
His tag antibodies. The His tag was placed at the N-terminus of all recombinant KNL2 
variants (Supplemental Figure 1). The elution fractions of the KNL2 variants purification 
were separated on a 12% PAA gel (identical to Figure 4) and subsequently transferred on a 
PVDF membrane. The antibodies detected the His tagged proteins on the membrane. The 
designated bands of KNL2Nterm (65 kDa) and KNL2Cterm (38 kDa) appeared on blot 
membrane (Figure 5). However, the designated band for KNL2 could not be observed. The 
percentage of the acrylamide in the PAA gel was lowered to increase the resolution of the 
protein band of KNL2. Then, a signal for KNL2 was detected at 110 kDa on a blot 
membrane based on an 8% PAA gel (Figure 6). The additional bands below the designated 
bands of KNL2 variants were also detected by the anti-His tag Western blot.  
The designated bands as well some bands with lower molecular weights were analyzed by 
mass spectrometry* (Supplemental Figure 7, see 2.21 ). The designated bands of the KNL2 
variants were identified as the Arabidopsis KNL2 protein (Table 3). Moreover, the 
identification of the bands of lower molecular weight in the lanes of KNL2 and 
KNL2Nterm as Arabidopsis KNL2 indicates truncation of KNL2 variants at the C-terminal 
site. 
Although the molecular weight discrepancy in PAA gels could not be explained, the 
purified recombinant KNL2 variants were verified by Western blot and MS.  
                                                 
* In cooperation with Dr. Andrea Matros 
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Figure 5: The purified proteins of KNL2 variants (blue arrowed lanes) and the total protein extract (see 2.12) 
of induced E. coli cultures (orange arrowed lanes) were separated on a 12% SDS-PAA gel identical to Figure 
4 and subsequently blotted on a PVDF membrane. Primary anti-His tag antibodies and secondary anti-
mouse-HRP antibodies were applied on the PVDF membrane. The signals of HRP coupled secondary 
antibodies were gained on a chemoluminescent film. This film was exposed to the triggered light emitting 
HRP reaction for 1 min. Bands, which were identical to the designated bands of KNL2Nterm and 
KNL2Cterm, were highlighted by a red frame.  
 
 
Figure 6: The Western blot was 
performed according to Figure 5, except 
the usage of an 8% SDS-PAA gel. The 
same primary and secondary antibodies 
were used and the exposure time of the 
chemoluminescent film to the triggered 
HRP reaction was 6 h. Signals 
highlighted by a red frame appeared at the 
position of designated bands of KNL2 
(Figure 4). 
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Table 3: The picked gel spots of Supplemental Figure 7 were analyzed by MALDI-TOF mass spectrometry. 
All spots were identified by the older KNL2 database entry gi|7413641 (Supplemental Figure 8) with the 
exception of the unidentified spot 2b. The MASCOT score above 90 indicate statistical significant hits. 
Moreover, the number of gained peptides and the sequence coverage of peptides to the whole protein 
sequence are shown. 
Spot/ 
protein 
Protein (NCBI- or BLAST-hit in 
“plant” or “all entries” database) 
Genbank 
accession 
MASCOT 
Score Peptides 
Sequ. 
cov. % 
1a 
KNL2 
putative protein [Arabidopsis 
thaliana] 
gi|7413641 301 5 10 
1b 
KNL2 
putative protein [Arabidopsis 
thaliana] 
gi|7413641 301 5 10 
2a 
KNL2N 
putative protein [Arabidopsis 
thaliana] 
gi|7413641 215 2 4 
2b 
KNL2N 
Not identified     
3a 
KNL2C 
putative protein [Arabidopsis 
thaliana] 
gi|7413641 489 5 10 
3b 
KNL2C 
putative protein [Arabidopsis 
thaliana] 
gi|7413641 482 6 12 
4a 
KNL2 
putative protein [Arabidopsis 
thaliana] 
gi|7413641 145 1 2 
4b 
KNL2 
putative protein [Arabidopsis 
thaliana] 
gi|7413641 346 5 9 
5a 
KNL2N 
putative protein [Arabidopsis 
thaliana] 
gi|7413641 253 4 6 
5b 
KNL2N 
putative protein [Arabidopsis 
thaliana] 
gi|7413641 257 4 6 
 
4.2 Characterization of KNL2 
The verified, recombinant KNL2 variants were used for the subsequent characterization 
studies. 
 
4.2.1 Characterization of DNA-binding capability of KNL2 
The hypothetical DNA binding of KNL2 protein variants should be analyzed (see 1.7 & 
4.1.4.1). Two EMSA approaches were performed (see 2.22): an agarose gel and a native 
PAA gel based approach. In general, the KNL2 protein variants and the typical 
Arabidopsis centromere repeat cen180 (see 1.3 & 1.4) were mixed. The cen180 repeats 
were obtained by PCR and subsequently purified (see 2.4 & 2.5). The protein samples 
were obtained from a urea containing denaturing purification approach (see 2.16.2).  
In the agarose gel based EMSA (see 2.22.1) no shift occurred in the lanes of cen180 mixed 
with KNL2 or KNL2Nterm (Figure 7). However, the band of cen180 mixed with 
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KNL2Cterm was shifted above 180 bp. The proteins in the agarose gel were transferred on 
a nitrocellulose blot membrane, where the proteins were detected by anti-His tag 
antibodies (see 2.20.1 & 2.22.1). Only signals for the KNL2Cterm protein appeared 
(Figure 8). No signals were detected for KNL2 and KNL2Nterm proteins. A merging of 
the agarose gel signal into the blot membrane indicated a small shift in DNA and protein 
bands for the cen180-KNL2Cterm mixture (Supplemental Figure 9).  
The EMSA method was changed to a PAA gel based approach (see 2.22.2) to get the 
signals of KNL2 and KNL2Nterm proteins, because these two proteins might enter PAA 
gels better than agarose gels. Native PAA gels loaded with KNL2 or KNL2Nterm showed 
again no shift of the cen180 signal. However, both proteins can be detected by anti-His 
tag-HRP antibodies (Figure 9 & 10). The cen180 bands were clearly shifted in lanes loaded 
with a mixture of KNL2Cterm and cen180 sequences (Figure 11). The signal at 180 bp 
disappeared and shifted near to the slots. A merging of Western blot signals of His tagged 
proteins into the native PAA gel with SYBR® safe stained DNA indicated overlay of 
shifted cen180 and KNL2Cterm signals (Figure 12). This indicates a protein-DNA 
interaction for KNL2Cterm, but not for KNL2Nterm and KNL2.  
The urea concentration in the protein-DNA could inhibit protein-DNA interaction in the 
PAA gel based approach. However, if a shift is observed even in urea containing samples, 
it must be a protein-DNA interaction (see 5.3.2). On the other hand, proteins could 
precipitate at low urea concentrations and misfolded or aggregated proteins are supposed to 
be not able to form protein-DNA complexes. Urea was omitted in the agarose gel based 
EMSA by dialysis (see 2.22.1). 0.5 M urea was the final concentration in PAA gel based 
EMSA to ensure solubility. Based on the urea concentration all KNL2 variant samples 
were partially precipitated in the agarose based EMSA and the samples used in the PAA 
gel based EMSA were soluble. In an additional approach, the urea concentration was 
decreased as much as possible in a PAA based approach to find an optimal compromise. 
KNL2 and KNL2Nterm were still soluble at 0.19 M urea. In general, KNL2Cterm was 
soluble after removal of urea (see 2.26 & 4.2.4). However, the sample of KNL2Cterm used 
in this approach precipitated. The protein samples were used, because KNL2Cterm showed 
in agarose based approach already DNA binding capability, although precipitation was 
visible in the protein sample indicating soluble proteins were present too. KNL2 variants 
dialyzed in different urea concentrations (0.5 M, 0.19 M and without urea) were mixed 
with centromeric cen180 fragments and subsequently a PAA gel based EMSA was 
performed. The signals of cen180 and KNL2 variants were merged together and the results 
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indicated no essential difference between the protein-DNA mixtures containing 0.5 M urea 
and minimum concentrations (Supplemental Figure 10). 0.5 M urea as well as some degree 
of insolubility might not bias the shift of the cen180 band. Two minor unexpected findings 
were observed: a decreased signal of cen180 at 180 bp in the lane of the cen180-
KNL2Nterm mixtures containing less urea, and a larger shape of the KNL2Cterm protein 
signal in the lane containing no urea.  
A competition assay approach with poly dI/dC was performed to verify the specificity of 
the KNL2Cterm induced shift of cen180 bands. The KNL2Cterm protein sample without 
urea was used. No shift at all was observed (Figure 13). Experimental bias might happen. 
The EMSA experiments show no DNA interaction of cen180 repeats and KNL2 and 
KNL2Nterm at all. Shifts for KNL2Cterm containing mixture could be shown indicating 
DNA binding capability. However, a specific DNA binding could not be proven.  
 
Figure 7: A 1% agarose gel based 
EMSA was performed to check the 
interaction of the centromeric 
sequence cen180 with the KNL2 
variants. No shift can be observed for 
the KNL2 and KNL2Nterm 
(KNL2N) mixture in comparison to 
the 180 bp big cen180 band, whereas 
the mixture of KNL2Cterm (KNL2C) 
and cen180 showed a small shift 
(marked by arrows).  
 
 
Figure 8: The 1% agarose gel (Figure 
7) of the EMSA experiment was blotted 
on a nitrocellulose membrane by 
capillary blotting. Subsequently the 
recombinant KNL2 variants were 
bound by anti-His tag-HRP antibodies 
and the emitted light caused by the 
triggered HRP reaction was detected on 
a chemoluminescent film after 5 s 
exposure. Only signals were detected in 
lanes containing KNL2Cterm.  
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Figure 9: The protein 
KNL2 and centro-
meric sequence 
cen180 were mixed 
according to defined 
molecular ratios and 
loaded on an 8% 
native PAA gel. The 
band of cen180 did 
not shift through 
rising amounts of 
KNL2. The proteins 
were denaturated 
with SDS and 
transfer on a PVDF 
membrane. Anti-His 
tag-HRP antibodies 
was used to detect KNL2 proteins. After the HRP reaction the chemoluminescent film was exposed for 10 s. 
Signals of the chemoluminescent film were merged into the native PAA gel and signals for KNL2 were 
visible at the slots of each KNL2 containing lane.  
 
Figure 10: The 
protein KNL2Nterm 
(KNL2N) and the 
cen180 sequence 
were mixed accord-
ing to defined mole-
cular ratios and load-
ed on an 8% native 
PAA gel. There is no 
shift for the 180 bp 
big band of cen180 
observed due to 
KNL2Nterm. KNL2-
Nterm were loaded 
with SDS and sub-
sequently transferred on a PVDF membrane. A Western blot with anti-His tag-HRP antibodies was 
performed. The HRP reaction was detected on a chemoluminescent film for 10 s. The signals of KNL2Nterm 
can be observed at the slots of each lane, where KNL2Nterm was loaded.  
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Figure 11: KNL2Cterm protein (KNL2C) and the centromeric DNA sequence cen180 were mixed according 
to defined molecular ratios and loaded on an 8% native PAA gel. There was a shift of the cen180 band at 
180 bp to a position near to the slots. The shift got clearer with higher molecular ratio of KNL2Cterm. 
 
Figure 12: The KNL2Cterm (KNL2C) proteins, which were included in the EMSA experiments of Figure 
11, were loaded with SDS and subsequently detected by Western blot (see 2.20) with anti-His tag-HRP 
antibodies. The signals of the HRP reaction were detected on a chemoluminescent film with an exposure time 
of 10 s and were merged in Figure 11. There was an overlay of signals of the shifted centromeric cen180 
band and the signals of the antibodies detected KNL2Cterm protein.  
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Figure 13: A PAA gel based EMSA experiment (see 2.22.2) was performed with the centromeric cen180 
sequence and the KNL2Cterm (KNL2C) protein. The protein-DNA mixture and mixture with the DNA 
binding competitor poly dI/dC were loaded on a native 7% PAA gel. The DNA was stained by SYBR® Safe. 
No shift of the 180bp band of cen180 was observed.  
4.2.2 Characterization of the interaction of KNL2 and CenH3 
Human KNL2 does not interact with CENPA directly (see 1.6.1). The interaction of the 
two corresponding Arabidopsis homologues was checked with a BiFC assay (see 2.23) to 
analyze their interaction in planta. Fluorescence signals were obtained by KNL2- and 
KNL2Cterm-split YFP fusion proteins co-expressed with CenH3-split YFP fusion in 
tobacco. Also, CenH3 fusion controls without KNL2 variants showed signals 
(Supplemental Figure 11 & Supplemental Table 1). Therefore, neither the existence of a 
binding nor the non-existence could be proved. The experiments has to be repeated and it 
is recommended to include CENPC homologue (see 1.6.1) or other protein-protein 
interaction studies like co-immunoprecipitation or yeast/bacterial two hybrid selection 
systems might be applied (Golemis (Ed.), 2002).  
 
4.2.3 Characterization of possible phosphorylation of KNL2 
The suggested phosphorylation of KNL2 shall be analyzed in this chapter (see 1.6.2).  
4.2.3.1 In silico analysis of co-expression of Arabidopsis Aurora kinases and 
KNL2 
In silico analysis (see 2.24) was performed to characterize the expression of KNL2 and 
certain candidate kinases as well as CenH3. The results of the analysis using the software 
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CORNET and a set of microarrays predefined by the program (in total 425 experiments) 
showed a significant correlation of expression of selected genes (correlation coefficient 
above 0.5) (Figure 14).  
Aurora kinase 1, Haspin kinase Aurora kinase 3 seems to be reliable candidates for KNL2 
kinases.  
 
Figure 14: The in silico 
co-expression analysis 
(see 2.24) compared 
following Arabidopsis 
candidates: KNL2, all 
three Aurora kinases 
(AUR1-3 = Aurora kinase 
1-3), CenH3 and Haspin 
kinase as well. The color 
of the lines between the 
candidates represents the 
Pearson correlation 
coefficient. 
 
 
4.2.3.2 Aurora kinase 3 phosphorylates KNL2 in vitro 
Aurora kinase 3 was chosen for the kinase assay* (see 5.3.3.2). Only one kinase was used 
first, because of the limited time. The kinase assay reaction included two denaturing PAA 
gels, one with the three KNL2 variants and Aurora kinase 3 (Figure 15) and another one 
without kinase (Supplemental Figure 12). All three KNL2 variants and Aurora kinase 3 
bands showed phosphorylation signals in the kinase reaction gel (Figure 16). Minor signals 
were visible in the control reaction without Aurora kinase 3 for KNL2Nterm and 
KNL2Cterm (Supplemental Figure 13). However, the signal strength was not comparable 
to the assay with Aurora kinase 3.  
These results showed a phosphorylation at N- and C-terminal sites of KNL2 by Aurora 
kinase 3 and putative Aurora kinase phosphorylation sites were found within N- and C-
terminal parts by amino acid sequence analysis (Supplemental Figure 14). 
                                                 
* In cooperation with Dr. Dmitri Demidov and Eva Tomaŝtiková 
 48 
 
Figure 15: The three KNL2 
variants, Aurora kinase 3 and other 
ingredients of the kinase assay (see 
2.25) were loaded on a 10% SDS-
PAA gel, separated by SDS-PAGE 
(see 2.17.1) and subsequently 
stained by Coomassie. The 
designated bands of KNL2 as well 
Aurora kinase 3 bands were 
marked by arrows. The KNL2 
variants were loaded unequally.  
 
 
 
 
 
 
 
Figure 16: The SDS-PAA gel of 
Figure 15 was analyzed by a 
phosphor-imager (see 2.25). Black 
bands indicate phosphorylation 
activity. The designated bands of 
the KNL2 variants, truncated 
products and Aurora kinase 3 were 
marked.  
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4.2.4 Analysis of specificity and application of anti-KNL2Cterm antibodies 
related assays 
Many methods of proteins characterization like immunostaining and Western blot rely on 
antibodies. Therefore, KNL2 specific antibodies were produced. KNL2Cterm was chosen 
as antigen, because this variant delivered the highest amount of purified protein (Figure 4) 
and KNL2Cterm were able to be refolded in a dialysis buffer without urea (see 2.26), while 
maintaining its solubility. 
 
Figure 17: The gained antiserum of rabbit 1 was added in different concentrations to two fixed antigens: 
KNL2Cterm and His tagged M1 protein of the Influenza virus. The bound anti-KNL2Cterm antibodies of the 
antiserum were detected by alkaline phosphatase coupled anti-rabbit antibodies. The triggered alkaline 
phosphatase reaction was measured by an ELISA reader. The ELISA titer characterized the binding of the 
antiserum to the antigen.  
 
Figure 18: An ELISA identical to Figure 17 was performed to characterize the antiserum gained from 
rabbit 2.  
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4.2.4.1 ELISA and Western blot experiments confirmed sensitive 
immunoreaction of anti-KNL2Cterm antibodies 
KNL2Cterm protein samples were injected* in two rabbits (named ‘1’ & ‘2’) according to 
2.27. Subsequently ELISA* was performed (see 2.28) to analyze the gained antisera. The 
ELISA results (Figure 17 & 18) show high ELISA titer of both antisera against 
KNL2Cterm. In contrast, the antisera gave less response to the control protein, which had 
just the His tag in common with KNL2Cterm. The antisera were purified or precipitated† 
according to chapter 2.29. 
Then, a Western blot was performed to quantify the reaction between purified or 
precipitated antibodies to the antigen KNL2Cterm. The results of the anti-KNL2Cterm 
antibodies 1 (of rabbit 1) are shown in Figure 19 and the antibodies 2 (of rabbit 2) gave 
similar Western blot signals (data not shown). Even 150 pg of the KNL2Cterm protein can 
be detected by Western blot using anti-KNL2Cterm antibodies 1. The expected designated 
band of KNL2Cterm appeared below 38 kDa. Moreover, bands above this molecular 
weight at 70 kDa were detected, indicating a dimer formation. Furthermore, the expected 
band for KNL2 at 110 kDa was visible, whereas no signals for KNL2Nterm appeared. 
The antibodies showed a good and sensitive response against the recombinant antigen, 
which indicated a working immune reaction against KNL2Cterm of both rabbits. 
 
Figure 19: Different amounts of 
the KNL2 variants were separated 
on an 8% SDS gel. Subsequently 
the gel was blotted on a PVDF 
membrane. Anti-KNL2Cterm 
antibodies 1 (Figure 17) and anti-
rabbit-HRP was applied on the 
membrane. The triggered HRP 
reaction was exposed to a 
chemoluminescent film for 30 min. 
Arrows indicate the designated 
bands of KNL2 (110 kDa) and 
KNL2Cterm (38 kDa).  
                                                 
* In cooperation with Ulrike Gresch  
† In cooperation with Ulrike Gresch and Isolde Tillack 
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4.2.4.2 Localization of KNL2 at chromocenter and in nucleoplasm of 
meristematic nuclei 
The anti-KNL2Cterm antibodies were used to perform immunostaining (see 2.30) on 
meristematic cells of Arabidopsis as well as in cells of the KNL2 SALK mutant. The KNL2 
SALK mutant is T-DNA-insertion line with a knock-out of KNL2 expression by a 
kilobase-big insertion in exon 4 of the KNL2 gene (Supplemental Figure 15). The 
immunostaining with the antibodies 1 & 2 on root tips and flower buds of Arabidopsis 
showed similar results. Specific, chromocentric signals and signals in nucleoplasmic 
background were seen on meristematic cells of Arabidopsis, whereas cells of KNL2 SALK 
mutants were stained at nucleoplasm only (Figure 20). The chromocentric signals were 
characterized by centromeric regions surrounded by heterochromatic, pericentromeric 
regions (see 4.2.4.3). No chromocentric signals of KNL2 antibodies were seen in M phase. 
KNL2 localize at chromocenteres only in interphase. 
4.2.4.3  Co-localization of KNL2Cterm and CenH3 in meristematic nuclei 
The anti-KNL2Cterm antibodies 1 and anti-GFP antibodies were used on root tips of 
EYFP-CenH3 stably transformed Arabidopsis thaliana plants (see 2.30.2). The signals of 
CenH3 and KNL2Cterm co-localized (Figure 21). Also, this co-localization could be 
observed at typical Arabidopsis chromocenters. SIM technology* was applied to get a 
better resolution (see 2.30.1). The co-localized signals of KNL2 and CenH3 are embedded 
into the heterochromatic pericentromere (Figure 22).  
4.2.4.4 Analysis of Arabidopsis ecotype Col-0 and KNL2 SALK protein 
extracts  
The whole cell protein extract of Arabidopsis thaliana ecotype Columbia-0 seedlings and 
KNL2 SALK mutant seedlings (see 2.14) were used for Western blot with anti-
KNL2Cterm antibodies. The result of the Western blot with anti-KNL2Cterm antibodies 2 
is shown in Figure 23. A band above 70 kDa appeared in the lanes of the wild type, 
however, not in the mutant. The expected molecular weight of KNL2 is 66 kDa. Some 
other bands with different molecular weight were visible on the film. They were present in 
the lanes of wild type and mutant samples.  
Thus, the preliminary data characterized the gained anti-KNL2Cterm antibodies as specific 
and sensitive.  
 
                                                 
* In cooperation with Dr. Veit Schubert 
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Figure 20: Immunostaining (see 2.30) of flower bud cells of Arabidopsis (1-3) and flower bud cells of KNL2 
SALK Arabidopsis mutants (4-6) was performed using anti-KNL2Cterm antiserum 2 and anti-rabbit-
rhodamine antibodies. (1/3) Rhodamine signals of the secondary antibodies were detected. (2/5) DAPI 
signals of the chromatin were shown. (3/6) Rhodamine and DAPI signals were merged. White arrows 
indicate chromocenters.  
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Figure 21: Immunostaining of root tips of Arabidopsis plants stably expressing EYFP-CenH3 fusion 
constructs with anti-GFP antibodies and protein A purified anti-KNL2Cterm antibodies 1 (Figure 17, see 
2.29.1). 3D microscopy technique was applied for analysis of fluorescence (see 2.30.1). (1) Rhodamine 
signals for KNL2. (2) DAPI signals for chromatin. (3) Dylight® 488 signals for CenH3-EYFP fusion 
protein. (4) Merge of rhodamine and dylight® 488 signals.  
 
 
Figure 22: The Structured 
Illumination Microscopy was 
applied on immunostaining 
samples of Figure 21. The red 
color shows the position of 
KNL2. CenH3 is represented by 
the green color. Yellow indicate 
the co-localization of CenH3 and 
KNL2. DAPI stain chromatin. 
Condensed blue staining is 
condensed, heterochromatic, 
pericentromeric DNA.  
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Figure 23: 20 μg of protein samples isolated from seedlings of Arabidopsis thaliana ecotype Col-0 (wild 
type) and KNL2 SALK mutant were separated on a 10% SDS-PAA gel. The protein samples were transferred 
from the gel to a PVDF membrane. Ammonium sulfate precipitated anti-KNL2Cterm antibodies 2 were 
applied (Figure 18, see 2.29.2). Subsequently the secondary anti-rabbit-HRP antibodies were used. The 
triggered HRP reaction was captured by a chemoluminescent film for 5 min. The arrow marks bands for 
KNL2.  
 
 55 
5 Discussion 
 
5.1 Main findings of the study 
 
The recombinant KNL2 proteins were successfully expressed and purified. The C-terminal 
part of KNL2 showed indications for a DNA binding capability, but not the N-terminal 
part and the full length fragment. KNL2 was phosphorylated on multiple sites by Aurora 
kinase 3. CenH3 and KNL2 co-localized at chromocenters of meristematic Arabidopsis 
thaliana interphase nuclei. 
 
5.2 KNL2 protein variants are purified, however, some non-expected 
observations arise 
 
The specificity of purified KNL2 protein variants were validated by mass spectrometry and 
Western blot analysis (see 4.1.4.2). Therefore, all confirmed KNL2 variants were used for 
further characterization (see 5.2.2). 
Nevertheless, two experimental observations were not expected: the KNL2 protein variants 
showed not the expected molecular weights in SDS-PAA gels (see 5.2.1) and some 
products of smaller molecular weight appeared additionally to the designated main protein 
bands (see 5.2.2). 
 
5.2.1 Posttranslational modification or experimental conditions influence the 
size discrepancy of KNL2 variants in PAA gels 
The KNL2 variants showed not expected molecular weight in SDS-PAA gels. We 
supposed different possibilities for this size differences (see 4.1.4.1): post-translational 
modification, homo-dimerization and DNA binding.  
Certain posttranslational modifications like phosphorylation and glycosylation can lead to 
an impaired SDS of the proteins (Weber et al., 1972; Green and Sambrook, 2012). 
Phosphorylation and glycosylation are post-translational modifications in eukaryotes and 
prokaryotes (Dell et al., 2010). The recombinant, over-expressed eukaryotic KNL2 
proteins may be modified in E. coli by modifications like the non-enzymatic gluconolation 
(Stryer, 1995; Aon et al., 2008). Moreover, recombinant KNL2 proteins have a lot of 
aspartic acid, histidine, serine and threonine residues, which might be phosphorylated by 
bacterial kinases (Supplemental Figure 14) (Pereira et al., 2011).  
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Proteins with higher charge might migrated differently in SDS-PAA gels than proteins of 
the same size with neutral net charge (Weber et al., 1972; Green and Sambrook, 2012). 
KNL2 and KNL2Cterm have an increased isoelectric point (pI) (Supplemental Table 2). 
However, these values are not comparable to the pI of CenH3 and other histones, which 
show atypical electrophoretic mobility caused by their high positive net charge (Weber et 
al., 1972).  
Our data did not support the hypothesis, that protein-DNA interaction lead to the size 
discrepancy of KNL2 protein variants in SDS-PAA gels (see 4.1.4.1.2). Usually protein-
DNA complexes are relative labile even in native PAA gels and rapid dissociation may 
occur during electrophoresis (Hellman and Fried, 2007; Sidorova et al., 2010). Therefore, 
presence of stabile protein-DNA complexes, especially in denaturating SDS-PAA gels, 
may be regarded as unlikely. However, some investigators report about protein-DNA 
complexes in denaturating gels (Naryzhnyi, 1992). Nevertheless, this phenomenon was not 
the proven in this study.  
Several investigators found stable dimers of other proteins in SDS-PAA gels (Gherardi and 
Coffer, 1991; Isbert et al., 2012; Hauptmann et al., 2013). However, our experimental data 
do not show a homo-dimerization of KNL2 variants (see 4.1.4.1.1). 
We were unable to verify our suggestions for the impaired molecular weight 
experimentally. Therefore, posttranslational modifications and some not controlled or 
biased experimental conditions may lead to the outcome. The ratios of observed molecular 
weight to expected molecular weight of KNL2 and KNL2Nterm are higher than the ratio of 
KNL2Cterm (Table 2). This indicates a correlation between the N-terminal part and the 
increased molecular weight. However, the molecular weight of the KNL2Cterm band 
differs among the experiments (see 4.1.4.1). To solve this discrepancies we would suggest 
to ensure the expression of KNL2 protein variants in inclusion bodies by raising the 
expression temperature and inducer concentration followed by isolating, washing, 
denaturating and renaturating inclusion body proteins (Simpson, 2003; Green and 
Sambrook, 2012). Proteins captured in inclusion bodies shall be protected from 
posttranslational modification (Sahdev et al., 2008). If the size discrepancy would be still 
detected, changing the expression vector and the host strain may overcome possible 
experimental bias.  
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5.2.2 C-terminal truncation of KNL2 variants might be caused by proteolysis 
or translational error 
The designated main protein bands of KNL2 variants consist of estimated 10-70% of the 
whole protein purification depending on each variant (see Figure 4 & Supplemental Figure 
12). Stable KNL2 protein variants were obtained, however, optimization is required. The 
truncation of the KNL2 protein variants happens at the C-terminal site, because the N-
terminal His tag was intact and detected by the anti-His tag antibodies (see 4.1.4.2). This 
truncation may have two possible sources: the activity of bacterial C-terminus specific 
endoproteases or exopeptidases (Miller, 1975) or ‘codon usage bias’ (Green and 
Sambrook, 2012).  
BL21 strain is deficient in the proteases lon and ompT to decrease the degradation of 
expressed recombinant proteins (Green and Sambrook, 2012). However, E. coli cells 
contains more than 20 proteolytic enzymes (Murby et al., 1996) and they are needed to 
maintain a physiological protein level and cellular homeostasis. Therefore, the C-terminal 
degradation of recombinant proteins by E. coli enzymes like HflB, Clp (Herman et al., 
1998) or dcp proteases (Henrich et al., 1993) may occur. However, the non-polar character 
of last five amino acids of the C-terminus determines the activity of C-terminus specific 
proteases in E. coli (Parsell et al., 1990) and just 2 of the last 5 amino acids of the C-
terminus of KNL2 protein variants are non-polar (Supplemental Figure 14). Three 
approaches can be applied to avoid degradation: I) separating the protein from proteases by 
isolating inclusion bodies, because recombinant proteins are protected from degradation 
inside inclusion bodies (Schoner et al., 1985; Wheelwright, 1991), II) separating the 
protein from proteases the by fusing a leader signal peptide to recombinant proteins to 
induce their secretion out of the host cell cytoplasm (Murby et al., 1996) and III) adding 
other protease inhibitors like AEBSF, leupeptin, benzamidine or E-64 together with the 
serine protease inhibitor PMSF to ensure stable inhibition of serine and cysteine proteases. 
EDTA inhibits metallo-proteases. However, EDTA cannot be applied, because this 
chelating agent disturb the down-stream IMAC purification procedure (Green and 
Sambrook, 2012).  
“Codon usage bias […] is usually defined as a species-specific deviation from uniform 
codon usage in the coding regions of genomic sequences.”(Fox and Erill, 2010) If many 
codons, which are rarely used in E. coli, are present in the coding sequence of the inserted 
eukaryotic genes, translational errors like frame-shifts and truncations will arise (Kane, 
1995). The sequences of KNL2 variants contain around 8% of rare codons (Supplemental 
Table 3). Even one rare codon might be enough to decrease the efficiency of translation 
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(Kane, 1995). The codon bias can be overcome by using the Rosetta 2 strain instead of the 
BL-21 strain, additionally the gene sequences can be optimized for codon usage in E. coli 
by several companies (Green and Sambrook, 2012). These approaches might help to 
decrease truncation and improve expression of KNL2 variants in vivo.  
The total protein extracts of induced E. coli cells show weaker signals for bands of 
truncated KNL2 protein variants in the developed Western blot film as the elution fractions 
of the protein purification (Figure 5). In the total protein extracts protein degradation 
should be inhibited through the applied sample buffer and sample treatment (Green and 
Sambrook, 2012). However, some investigators suggest treating the cells with incubation 
at 85°C for 3 min instead of 15 min incubation at 65°C to ensure the denaturation of all 
proteases (Grabski and Burgess, 2001). Nevertheless, these results indicate proteolytic 
degradation during the purification procedure and translation errors are also possible. 
Therefore, we suppose to use Rosetta 2 strain for protein expression and add additional 
protease inhibitors during protein purification to gain intact KNL2 protein variants. Non-
degraded protein solutions are better binding partner in EMSA experiments, because the 
whole protein can be necessary to form the protein-DNA complex (Simpson, 2003) (see 
5.3.2). Partially truncated protein solutions are sufficient for kinase assays or for antibody 
production, because KNL2 variant serve as substrates and biological activity must not be 
alter by degradation (Simpson, 2003).  
 
5.3 Characterization of KNL2 as centromeric protein with indicated 
DNA binding capability and Aurora 3 phosphorylation sites 
 
5.3.1 KNL2 localizes at chromocenters during interphase detected by specific 
antibodies 
The produced anti-KNL2Cterm antibodies show sensitive reaction in ELISA and Western 
blot (see 4.2.4.1). The KNL2Cterm protein is better recognized than the control protein by 
anti-KNL2Cterm antibodies in ELISA and 150 pg of KNL2Cterm and 15 ng of KNL2 
were detected in Western blot analysis, whereas KNL2Nterm is not. Additionally dimer 
formation was observed in the Western blot of the related SDS-PAA gel. Such 
dimerization in denaturating PAA gels are observed by other investigators (see 5.2.1).  
These antibodies showed immunostaining signals at chromocenters and nucleoplasm of 
meristematic interphase nuclei of Arabidopsis thaliana (see 4.2.4.2). Chromocenters are 
distinct, dense bodies formed by peri-/centromeric heterochromatin, which ensure 
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centromeric function (Karpen and Allshire, 1997; Tiang et al., 2012). In nuclei of KNL2 
SALK mutants, anti-KNL2 immunostaining signals were detected only in nucleoplasm. 
We suppose that the nucleoplasmic signal is a result of unspecific staining by KNL2-
unspecific antibodies present in the sample of purified IgGs and we can not exclude that 
the KNL2 specific antibodies can bind multiple epitopes and label nucleoplasmic 
Arabidopsis proteins. Nevertheless, the centromeric signals are specific for wild type. 
Centromeric signals during interphase are also obtained by Lermontova et al. (2013) using 
KNL2-EYFP or KNL2Cterm-EYFP fusion constructs stably expressed in Arabidopsis 
thaliana. The signal of anti-KNL2Cterm antibodies co-localize with CenH3 at 
chromocenters (see 4.2.4.3). This indicates a close spatial relationship and possible 
interaction between those two proteins. Finally a Western blot with the produced 
antibodies (see 4.2.4.4) shows the related band of native KNL2. Other bands were also 
detected. This might have the same reason as the nucleoplasmic staining in the 
immunostaining experiments. In summary, these results show the antibodies are sensitive 
and specific and they shall be used in future work like co-immunoprecipitation or ChiP 
experiments (Golemis (Ed.), 2002; Collas, 2010) and KNL2 is incorporated into 
centromeric regions. 
 
5.3.2 Characterization of DNA-binding capability of KNL2Cterm in a 
proposed regulatory network 
The interaction between KNL2 protein variants and the cen180, the centromeric repeat 
sequence of Arabidopsis, was verified by EMSA experiments (see 4.2.1). KNL2Cterm 
induce a shift of the cen180 band indicating a protein-DNA interaction, however, KNL2 
and KNL2Nterm do not show such a shift.  
The open question is: why does KNL2Cterm shows protein-DNA interaction, whereas 
KNL2 not? Maybe the experimental biases like the urea concentration, degradation or non-
native conformation are the reasons. Thus, KNL2 protein variants must be isolated in a 
soluble form with native conformation without degradation. Protein expression in 
eukaryotic expression systems (Rosenberg, 2005; Green and Sambrook, 2012) or following 
experimental changes may help to increase solubility: lowering of the expression 
temperature and inducer concentration (Schein and Noteborn, 1988; Green and Sambrook, 
2012), altering media composition and host strain (Simpson, 2003; Green and Sambrook, 
2012), co-expressing molecular chaperones (Amrein et al., 1995; Murby et al., 1996), 
fusing the protein to protein tags with high solubility like MBP (Baneyx, 1999) and adding 
‘stabilizer’ like sorbitol or glycyl betaine (Blackwell and Horgan, 1991). However, 
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KNL2Cterm shows DNA binding capability even in 0.5 M urea or in precipitated state of 
the protein sample, whereas KNL2 and KNL2Nterm do not induce a shift of cen180 under 
the same conditions. Some investigators show protein-DNA interaction in 0.2 M urea 
(Cohen et al., 1996). Therefore, we hypothesize that KNL2Nterm may inhibit the DNA 
binding to give another explanation of the different behavior of KNL2 and KNL2Cterm in 
the EMSA experiments. Such intramolecular inhibitory mechanism is known in many 
transcription factors of eukaryotic organisms: mouse Isl1 (Gadd et al., 2013), human 
CDP/Cux (Truscott et al., 2004), human p63 (Serber et al., 2002), Swi4 in Saccharomyces 
cerevisiae (Baetz and Andrews, 1999) and b-Myb in Xenopus (Humbert-Lan and Pieler, 
1999). In general “[c]onformational changes, including local protein folding, play 
important roles in protein-DNA interactions” (Petersen et al., 1995).  
We would like to propose a model to the hypothesis to explain the difference between 
centromeric localization of KNL2 during whole interphase and the assumed ‘licensing and 
priming’ activity during G2 phase (see 1.5). KNL2 is probably not active during G1 phase 
and may be regulated by an internal mechanism. According to our model KNL2 is 
incorporated in the inner kinetochore throughout interphase and inactive during G1 by an 
intramolecular inhibitory mechanism. During G2 phase intramolecular transition stops the 
inhibition of the C-terminal DNA binding capability. KNL2 is ‘anchored’ to the DNA and 
chromatin remodeling complexes like H3K9 methyltransferases (Lermontova et al., 2013) 
are loaded close to their target DNA sites possibly by the N-terminal SANTA domain. This 
network based on KNL2 lead to the ‘priming and licensing’ of CenH3 assembly, which is 
stopped at the beginning of M phase by the removal of KNL2 from kinetochore. An EMSA 
experiment with the mixture of KNL2Nterm and KNL2Cterm can verify the hypothesis of 
the intramolecular regulation (Humbert-Lan and Pieler, 1999). Additionally the EMSA 
experiment with the DNA binding competitor (Figure 13) has to be repeated to verify the 
specificity of the DNA binding capability.  
Then, the question arises: how is the nuclear deposition of KNL2 during interphase and the 
absence during M phase determined (Lermontova et al., 2013) (see 4.2.4.2 & 5.3.1)? Life 
cell imaging experiments of Arabidopsis thaliana root tip cells stably transformed with the 
EYFP-KNL2/KNL2Nterm/KNL2Cterm fusion construct showed no fluorescence during 
mitosis (Lermontova et al., 2013). Therefore, the absence of KNL2 at chromocenters 
during M phase is independent of the N-/or C-terminus. The DNA binding capability of 
human KNL2 C-terminus is recently described as non-specific to a sequence motif and 
interacting with DNA in a novel fashion (Maddox, 2013). These findings support the 
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‘anchoring’ function of the C-terminus. If this mechanism is also conserved in Arabidopsis 
KNL2 C-terminus, the regulation of nuclear localization of KNL2 at chromocenters might 
be not determined by the C-terminal DNA binding alone. In the next chapter (see 5.3.3.3), 
we suppose such regulatory network for KNL2 localization.  
Two unexpected findings of the EMSA experiments shall be discussed. 1) KNL2Nterm 
dissolved in 0.19 M urea showed a signal reduction of cen180 band at 180 bp indicating 
some protein-DNA interaction (Supplemental Figure 10). Soluble KNL2Nterm protein 
solution without urea is needed to verify this effect. 2) In the same experiment 
KNL2Cterm containing sample without urea shows more stretched His tag signal than the 
protein-DNA sample with 0.5 M urea. This indicates a better mobility of the protein-DNA 
complex. The urea concentration might not influence the shift of cen180, however, it affect 
the stability of protein-DNA complex during electrophoresis.  
 
5.3.3 Phosphorylation of KNL2 by Aurora kinase 3 and a proposed KNL2 
localization model 
 
5.3.3.1 Introduction of putative KNL2 kinases 
The localization of Arabidopsis KNL2 at the kinetochore might depend on phosphorylation 
(see 1.6.2). Four candidate kinases of KNL2 are proposed by in silico co-expression 
analysis (see 4.2.3.1): Aurora kinases 1, 2 and 3; and Haspin kinase.  
 
5.3.3.1.1 Aurora kinases in Arabidopsis thaliana 
The three types of Arabidopsis Aurora kinases share a conserved enzymatic Ser/Thr kinase 
domain (Demidov et al., 2005; Kawabe et al., 2005). Aurora kinases phosphorylate histone 
3 at serine 10 (Demidov et al., 2005; Petrovska et al., 2012). This is an important 
epigenetic mark, which often occurs with heterochromatic H3K9me2 modification (see 
1.3) at pericentromeric sites in cell cycle dependent manner in mitosis (Gernand et al., 
2003; Fuchs et al., 2006; Eberlin et al., 2008). Furthermore, H3S10ph may have other 
functional importance. For instance, it negatively affects H3K9 methylation. H2S10ph can 
be established independently of H3K9 methylation and it is involved in regulation of 
transcription of centromeric sequences (Demidov et al., 2009). Some investigators suggest 
a phosphorylation of CenH3 by Aurora kinases (Kurihara et al., 2006). Arabidopsis plants 
with deregulated expression of Aurora kinase show defects in cell division. Overall Aurora 
kinases have mitotic function, are expressed during mitosis and most abundant in dividing 
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cells. The mitotic expression differs between the three kinases: Aurora kinase 1 shows very 
high (≈6000 normalized signals), Aurora kinase 3 moderate (≈2000 signals) and Aurora 
kinase 2 low mitotic expression (≈1000 signals) (Demidov et al., 2005). 
The localization of the Aurora kinases differs during the cell cycle, too. Aurora 1 and 2 are 
localized at cytoplasm and nucleus during interphase and during M phase both kinases are 
associated with spindle microtubules (Demidov et al., 2005; Kawabe et al., 2005; Van 
Damme et al., 2011). However, Aurora kinase 3 has different localization pattern: during 
interphase it is localized in nucleus and cytoplasma (Demidov et al., 2005; Van Damme et 
al., 2011) or in cytoplasm and around the nucleus (Kawabe et al., 2005), and during mitosis 
at distinct spots corresponding peri-/centromeric regions (Demidov et al., 2005; Van 
Damme et al., 2011). 
 
5.3.3.1.2 Haspin kinase in Arabidopsis thaliana 
Haspin kinase is another Ser/Thr kinase, which phosphorylates histone H3 at threonine 3 
(Ashtiyani et al., 2011). H3T3ph can be found along the entire length of chromosome arms 
and is associated with chromosome condensation (Houben et al., 2007). H3T3ph and 
H3S10ph/H3S28ph differ in temporal and spatial phosphorylation pattern in vertebrates 
and plants indicating diverse regulatory function between Haspin and Aurora kinases 
(Polioudaki et al., 2004; Houben et al., 2007). In summary, H3S10ph/H3S28ph are 
associated with chromosome cohesion and are located at pericentromeric sites, whereas 
H3T3ph play a role in chromosome condensation and is observed over the entire 
chromosome arms. RNAi experiments of human Haspin lead to abnormal metaphase 
chromosome alignment indicating the role of Haspin in chromosome segregation (Dai and 
Higgins, 2005). In plants, less H3T3ph modification and no defects in mitotic cell cycle are 
observed in the Haspin RNAi down-regulated cells. However, complete depletion causes 
defects in embryo development (Ashtiyani et al., 2011). Moreover, Haspin kinase is highly 
expressed in proliferated tissues, and this kinase is enzymatically active throughout the cell 
cycle unlike Aurora kinases (Dai and Higgins, 2005; Ashtiyani et al., 2011). Haspin kinase 
is located in cytoplasm during interphase and invades the nucleus after the nuclear 
envelope breakdown. After the breakdown Haspin localizes with H3T3ph modifications 
over chromosomes, but not directly with dynamic mitotic structures (Kurihara et al., 2011). 
The expression of Haspin kinase seem to be controversial: some investigators found 
mitosis specific expression like Aurora kinase 2 (Kurihara et al., 2011), other report a 
expression over the whole cell cycle (Houben et al., 2007; Ashtiyani et al., 2011).  
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5.3.3.2 Interpretation of co-expression data of KNL2 kinase candidates 
Our candidates are important players for the regulation of cell division regarding their role 
in cohesion or condensation, microtubule formation or development. We performed a co-
expression analysis to pick one candidate for down-stream kinase assay (see 4.2.3.1). Co-
expression indicates functional interaction of the transcripts. Aurora kinase 2 shows the 
lowest correlation coefficient the in silico analysis. Aurora kinases 1 and 3 as well as 
Haspin kinase have comparable correlation coefficients. Therefore, all these kinases are 
the primary candidates and are considered for future work. We choose Aurora kinase 3 for 
kinase assay, because this kinase localize clearly at chromocentric spots during M phase in 
contrast to the other candidates.  
 
5.3.3.3 Aurora kinase 3 phosphorylates KNL2 and might regulate its 
localization 
Kinase assay showed phosphorylation of KNL2 by Aurora kinase 3 at both N-terminal and 
C-terminal parts (see 4.2.3.2). Additionally minor signals are gain for auto-
phosphorylation. Moreover, KNL2 variants contain one conserved phosphorylation motif 
in the additional C-terminal part derived from the expression vector (Supplemental Figure 
14). However, C-terminal truncated products show also phosphorylation (Figure 16 & 
Supplemental Figure 13, see 5.2.2). Therefore, co-immunoprecipitation of native KNL2 
and Aurora kinase 3 is recommended to verify these results. Nevertheless, the preliminary 
data show phosphorylation of KNL2 by Aurora kinase 3 and we want to propose following 
model. Aurora kinase 3 localizes at chromocenters after the nuclear envelope breakdown 
(see 5.3.3.1.1) and phosphorylates KNL2. Due to this phosphorylation KNL2 is removed 
from chromocenters (Lermontova et al., 2013) (see 1.6.2 & 5.3.2). After M phase Aurora 
kinase 3 leaves the centromeric positions (Kawabe et al., 2005) and KNL2 bind again inner 
kinetochore structures. Therefore, we suggest Aurora kinase 3 is involved in the 
localization of KNL2 during cell cycle.  
Future work with application of Aurora kinase specific inhibitors and knock-out or knock-
down of Aurora kinases’ expression as well as the analysis of phosphorylated sites by 
peptides based kinase assay (Demidov et al., 2009; Lermontova et al., 2013), can help to 
verify the mechanism and functional importance of KNL2 phosphorylation by Aurora 
kinase 3. 
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5.4 Conclusions 
CenH3 assembly factor KNL2 was identified in Arabidopsis thaliana by our group 
(Lermontova et al., 2013). Recombinant KNL2 protein variants (full-length, N- and C-
terminal parts) were successfully produced in E. coli and anti-KNL2 antibodies were 
successfully generated in rabbits against the C-terminal part of KNL2. Anti-KNL2 
antibodies showed immunostaining signals within nucleus and at chromocenters of 
meristematic interphase nuclei. No signals were detected at centromeres during mitosis. 
Double immunostaining experiments showed co-localization of CenH3 and KNL2 at 
chromocenters indicating assembly factor characteristics. C-terminal part of KNL2 showed 
interaction with 180 bp centromeric repeat sequence. Moreover, the specificity of this 
DNA binding has to be verified. An unspecific DNA binding capability would resemble 
the human homologue function. Aurora kinase 3 phosphorylates KNL2 at both N- and C-
terminal parts. This phosphorylation might regulate the localization of KNL2 during the 
cell cycle. 
 
5.5 Outlook 
 
Modification and optimization of our experiments is required to increase the solubility of 
KNL2 protein variants (see 4.1.2.2), decrease the truncation (see 5.2.2), evaluate the 
specificity of the DNA binding capability of C-terminal part of KNL2 (see 5.3.2) and 
check additional kinases for KNL2 phosphorylation (see 5.3.3.2). In short, we would like 
to express the KNL2 protein variants in a new expression system to tag the recombinant 
proteins with a solubility mediating MBP. The degradation can be controlled by secreting 
the recombinant proteins out of the cells or using additional protease inhibitors. Then, the 
EMSA experiments will be repeated with soluble proteins and a South-Western blot can be 
applied for verification. A suggested intramolecular inhibition mechanism can be 
controlled by mixing KNL2Nterm and KNL2Cterm (see 5.3.2). Remaining anti-KNL2 
antisera shall be purified by an antigen affinity chromatography and the Western blot 
experiments (see 4.2.4.4) can be modified to an antigen competition assay to verify the 
wild type specific KNL2 band. Several approaches can be applied to get further insights of 
the interaction between KNL2 and KNL2 kinases: a kinase assay with peptides of the 
predicted target sites, RNAi approaches of KNL2 kinases in Arabidopsis thaliana, kinase 
inhibitor treatment of Arabidopsis seedlings and a BiFC assay including KNL2 and the 
related kinases. Also experimental biases appearing at certain experiments have to be 
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verified (see 4.1.2.2, 4.1.4.1, 4.2.1, 4.2.2, 5.2.1 & 5.3.2). Additional experiments such as 
ChiP or co-immunoprecipitation are also required to get further insight in the biological 
function of KNL2 in Arabidopsis (see 4.2.2, 5.3.1 & 5.3.3.3).  
Finally we want to suggest rather long term projects, which have practical implications. 
The research on centromere and kinetochore proteins like KNL2 can provide the 
knowledge to construct minichromosomes as artificial chromosome cloning vectors, which 
can be used to manipulate crops (Sullivan et al., 2001). Furthermore, CenH3 is connected 
to the production of double haploid plants, because crossings between wild type and 
CenH3 null mutant can generate haploid progenies (Ravi and Chan, 2010). Double haploid 
plants play an important role in plant breeding. The possible connection between CenH3 
and KNL2 provide the assumption, that KNL2 as an upstream component of the CenH3 
assembly mechanism can substitute CenH3 in this context.  
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8 Appendix 
 
 
Supplemental Figure 1: The cDNA sequences of Arabidopsis thaliana KNL2 is annotated in the TAIR 
database (identifier: AT5G02520) or Uniprot database (identifier: F4KCE9). This sequence served as 
template for creation of an artificial N-terminal (KNL2Nterm) and C-terminal (KNL2Cterm) variant. At the 
site of an internal, in-frame ATG triplet (marked by a green background) KNL2Nterm ends and KNL2Cterm 
starts. Due to the insertion into the expression vector pDEST17 additional N- and C-terminal sequences of 
the vector are part of the recombinant KNL2 variants (KNL2, KNL2Nterm, KNL2Cterm) along with the 
corresponding cDNA sequences. The 6x His tag is important for later protein purification (see 2.16). 
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Supplemental Figure 2: Alignment (see 2.10) of the annotated KNL2 gene (KNL2cDNA) with the forward 
(KNL2-fw) and reverse (KNL2-rw) sequencing data of isolated expression vector, which carrying the KNL2 
insert. Stars indicate coverage of the three sequences. 
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Supplemental Figure 3: Alignment (see 2.10) of the N-terminal part of the annotated KNL2 gene (KNL2N) 
with the forward (KNL2N-fw) and reverse (KNL2N-rw) sequencing data of isolated expression vector, which 
carrying the KNL2Nterm insert. Stars indicate coverage of the three sequences. 
 
 77 
 
Supplemental Figure 4: Alignment (see 2.10) of the C-terminal part of the annotated KNL2 gene (KNL2C) 
with the forward (KNL2C-fw) and reverse (KNL2N-rw) sequencing data of isolated expression vector, which 
carrying the KNL2Cterm insert. Stars indicate coverage of the three sequences. 
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Supplemental Figure 5: Purified protein solutions were treated with DNase I (see 2.19.1) or strong reducing 
conditions (see 2.18) and subsequently analyzed in a 12% SDS-PAA gel. The designated bands (arrowed) of 
the KNL2 variants did not alter in molecular weight after treatment (Figure 4). 
 
 
Supplemental Figure 6: Purified protein solutions were treated with Benzonase (see 2.19.2) and 
subsequently analyzed in a 12% SDS-PAA gel. The designated bands (arrowed) of the KNL2 variants did not 
alter in the molecular weight after treatment. 
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Supplemental Figure 7: Purified protein solution of the KNL2 variants were separated on a 12% SDS-PAA 
gel and subsequently analyzed by mass spectrometry. The designated band of KNL2 (1), KNL2Nterm (2), 
KNL2Cterm (3) and bands with lower molecular weight of KNL2 (4) and KNL2Nterm (5) were picked twice 
(a/b). 
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Supplemental Figure 8: The older KNL2 database identifier gi|7413641 (genbank, 2006) and the latest 
identifiers AT5G02520 (TAIR, 2013) or F4KCE9 (Uniprot, 2011) (Supplemental Figure 1) were analyzed by 
a sequence alignment tool (see 2.10). There is a difference just in the last 14 C-terminal amino acids, which 
are missing in the sequence of the genbank identifier. 
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Supplemental Figure 9: The signals of agarose gel of the EMSA (Figure 7) and of the relating 
chemoluminescent film (Figure 8) were merged. A small shift in the cen180 signal as well as a shift in the 
signal of KNL2Cterm (KNL2C) could be observed, whereas there was no overlay of DNA and protein 
signals. 
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Supplemental Figure 10: A PAA gel based EMSA (see 2.22.2) was performed with the centromeric 
sequence cen180 and the KNL2 variants dialyzed in different concentrations of urea. DNA molecules were 
detected by SYBR® Safe staining and the KNL2 variants with a Western blot approach using the anti-
His tag-HRP antibodies (Miltenyi Biotec®, #130-092-785, HRP coupled, 1:5000) and a chemoluminescent 
film, which was exposed by a triggered HRP reaction for 10 s. No clear difference could be detected between 
KNL2 or KNL2Nterm (KNL2N) mixed with cen180 dissolved in a concentration of 0.5 M urea (red arrowed 
lanes) and KNL2 or KNL2Nterm mixed with cen180 dissolved in 0.19 M urea (dark blue arrowed lanes). 
The band at 180 bp of cen180 disappeared and shifted near to the slots in the lanes of KNL2Cterm (KNL2C) 
mixed with cen180 dialyzed in 0.5 M urea (red arrowed lane) and KNL2Cterm mixed with cen180 
containing no urea (light blue arrowed lane). However, the shape of the detected KNL2Cterm signal differed 
between both urea concentrations. Different molecular ratios were used for the different KNL2 variants 
according to their concentration after the purification (Figure 4). 
 
 83 
 
Supplemental Figure 11: The cDNA of CenH3, KNL2 or KNL2Cterm (Supplemental Figure 1) was inserted 
into the plasmids pSPYCE-35s and pSPYNE-35s. These constructs were used to transform Agrobacterium 
tumefaciens. Agrobacterium cultures were injected into Nicotiana benthamiana leaves. An expression of the 
three proteins coupled with N-terminal (YFP-Nterm by pSPYCE-35s) or C-terminal part (YFP-Cterm by 
pSPYCE-35s) of YFP was induced in planta. The lower epidermis of injected leaves was isolated and a DIC 
microscopy was performed (cross-reference). The results of the microscopy are presented in Supplemental 
Table 1. 
 
Supplemental Table 1: The results of the BiFC experiments (see 2.23 and Supplemental Figure 11) showed 
green nuclear fluorescence in any CenH3 containing combination of fusion constructs, whereas KNL2 and 
KNL2Cterm fusion constructs not. 
Coupled with YFP-Nterm Coupled with YFP-Cterm Nuclear fluorescence Y/N? 
  CenH3 CenH3 Y 
CenH3 Empty vector Y 
Empty vector CenH3 Y 
KNL2 CenH3 Y 
CenH3 KNL2 Y 
KNL2Cterm CenH3 Y 
CenH3 KNL2Cterm Y 
KNL2 KNL2 N 
KNL2Cterm KNL2Cterm N 
KNL2 Empty vector N 
Empty vector KNL2 N 
KNL2Cterm Empty vector N 
Empty vector KNL2Cterm N 
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Supplemental Figure 12: This SDS-PAGE of the three KNL2 variants is identical to Figure 15. However, 
Aurora kinase 3 was not added. The KNL2 variants were loaded unequally.  
 
 
Supplemental Figure 13: The SDS-PAA gel of Supplemental Figure 12 was analyzed by a phosphor-imager 
(see 2.25). Black arrowed bands indicate phosphorylation. The designated bands of the KNL2 variants were 
highlighted by arrows. 
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Supplemental Figure 14: The amino acid sequence of the KNL2 variants (Supplemental Figure 1 & Table 
2) were checked for conserved phosphorylation motifs of Aurora kinases. This putative conserved motif 
(underlined in the sequence) is R/K-R/K-X-pS/pT-(not P) (Nousiainen et al., 2006; Dephoure et al., 2008; 
Sardon et al., 2010). Every recombinant, expressed KNL2 variant contained the additional N-terminal and C-
terminal amino acids originated by the expression vector (Supplemental Figure 1). KNL2 contained the 
KNL2term part and the KNL2Cterm part. There are 43 aspartic acid residues (green) and 12 histidine 
residues (violet) spread over the whole sequences. These might be canonical target residues for E. coli 
kinases. Additionally 76 serine (red) and 34 threonine (blue) residues were found, which can be 
phosphorylated too (Pereira et al., 2011). The last five C-terminal amino acids contain two non-polar amino 
acids: leucine and proline.  
 
 
 
Supplemental Figure 15: The exon- (grey bars) intron- (lines between exons) structure of the KNL2 gene is 
shown. The term ‘KNL2 SALK mutant’ is referring to a TDNA insertion at exon 4 with the shown accession 
number. This figure is part of the publication of Lermontova et al. (2013) 
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Supplemental Table 2: The sequences of the recombinant KNL2 variant (Supplemental Figure 14) were 
analyzed in silico (http://web.expasy.org/compute_pi/) to obtain the values for the isoelectric point (pI). 
CenH3 has a pI value of 11.58. 
Protein pI 
KNL2 8.96 
KNL2Nterm 6.00 
KNL2Cterm 9.86 
 
 
Supplemental Table 3: Certain codons, which are less used by E. coli (Kane, 1995; Green and Sambrook, 
2012), were counted in the cDNA sequence of the KNL2 variants (see Supplemental Figure 1) by using in 
silico tools (http://www.kazusa.or.jp/codon/countcodon.html). 
 KNL2 KNL2Nterm KNL2Cterm 
AGG 11 6 7 
AGA 12 8 4 
AUA 8 6 2 
CUA 2 1 2 
CCC 4 3 2 
GGA 17 11 6 
Sum of raw codons 54 35 23 
Total codon number 652 416 290 
ratio 8,3% 8,4% 7,9% 
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